U.S. patent application number 12/427159 was filed with the patent office on 2009-08-13 for novel centromeric protein shugoshin.
This patent application is currently assigned to Japan Science & Technology Agency. Invention is credited to Yoshinori Watanabe.
Application Number | 20090203887 12/427159 |
Document ID | / |
Family ID | 34656191 |
Filed Date | 2009-08-13 |
United States Patent
Application |
20090203887 |
Kind Code |
A1 |
Watanabe; Yoshinori |
August 13, 2009 |
Novel Centromeric Protein Shugoshin
Abstract
The present invention is to provide meiosis-specific novel
kinetochore protein Sgo1 (shugoshin) derived from fission yeast
Schizosaccharomyces pombe, and a homologue or paralogue thereof
having a regulatory activity of chromosome segregation; and DNAs
encoding them; as a factor ensuring the retention of unidirection
and cohesion in sister centromere at meiosis I in cooperation with
cohesin. To elucidate the proteins protecting Rec8 during anaphase,
the present inventor screened in fission yeast genes for a gene
that inhibits mitotic growth and prevents sister chromatid from the
separation at anaphase, when co-expressed with Rec8. In this
approach, meiosis-specific protein Sgo1 that protects (Shugo)
centromeric Rec8 from the degradation at anaphase I was
indentified. Further, a budding yeast Sgo1 homologue and a fission
yeast mitotic paralogue Sgo2 were identified.
Inventors: |
Watanabe; Yoshinori; (Tokyo,
JP) |
Correspondence
Address: |
Locke Lord Bissell & Liddell LLP;Attn: IP Docketing
Three World Financial Center
New York
NY
10281-2101
US
|
Assignee: |
Japan Science & Technology
Agency
Kawaguchi-shi
JP
|
Family ID: |
34656191 |
Appl. No.: |
12/427159 |
Filed: |
April 21, 2009 |
Related U.S. Patent Documents
|
|
|
|
|
|
Application
Number |
Filing Date |
Patent Number |
|
|
10581158 |
Jan 30, 2007 |
7538191 |
|
|
PCT/JP04/17428 |
Nov 24, 2004 |
|
|
|
12427159 |
|
|
|
|
Current U.S.
Class: |
530/387.9 ;
530/350; 536/23.5 |
Current CPC
Class: |
C07K 14/47 20130101;
C07K 14/39 20130101 |
Class at
Publication: |
530/387.9 ;
536/23.5; 530/350 |
International
Class: |
C07K 16/00 20060101
C07K016/00; C07H 21/04 20060101 C07H021/04; C07K 14/435 20060101
C07K014/435 |
Foreign Application Data
Date |
Code |
Application Number |
Dec 1, 2003 |
JP |
2003-401943 |
Sep 27, 2004 |
JP |
2004-279450 |
Claims
1. An isolated DNA encoding a protein consisting of an amino acid
sequence shown in SEQ ID NO: 18.
2. An isolated DNA encoding a protein comprising an amino acid
sequence where one or several amino acids are deleted, replaced or
added in an amino acid sequence shown in SEQ ID NO: 18, and having
a regulatory activity of chromosome segregation.
3. An isolated DNA consisting of a base sequence shown in SEQ ID
NO: 17 or a complementary sequence thereof.
4. An isolated DNA containing part or whole of a base sequence
shown in SEQ ID NO: 17 or a complementary sequence thereof, and
encoding a protein that has a regulatory activity of chromosome
segregation.
5. An isolated DNA hybridizing with the DNA according to claim 3
under stringent conditions and encoding a protein that has a
regulatory activity of chromosome segregation.
6. An isolated protein consisting of an amino acid sequence shown
in SEQ ID NO: 18.
7. An isolated protein consisting of an amino acid sequence where
one or several amino acids are deleted, replaced or added in an
amino acid sequence shown in SEQ ID NO: 18, and having a regulatory
activity of chromosome segregation.
8. An isolated protein encoded by a DNA hybridizing with the
antisense strand of a DNA encoding the protein according to claim 6
under stringent conditions.
9. A fusion protein in which the protein according to claim 6 is
bound with a marker protein and/or a peptide tag.
10. A fusion protein in which the protein according to claim 7 is
bound with a marker protein and/or a peptide tag.
11. A fusion protein in which the protein according to claim 8 is
bound with a marker protein and/or a peptide tag.
12. An antibody specifically binding to the protein according to
claim 6.
13. An antibody specifically binding to the protein according to
claim 7.
14. An antibody specifically binding to the protein according to
claim 8.
15. The antibody according to claim 12, which is a monoclonal
antibody.
16. The antibody according to claim 13, which is a monoclonal
antibody.
17. The antibody according to claim 14, which is a monoclonal
antibody.
Description
[0001] This application is a divisional application of U.S. patent
application Ser. No. 10/581,158 filed Jan. 30, 2007, which is
national phase entry of International Application No.
PCT/JP2004/017428 filed on Nov. 24, 2004, which claims priority
benefit of Japanese Application No. JP 2003-401943 filed Dec. 1,
2003 and Japanese Application No. JP 2004-279450 filed Sep. 27,
2004, the contents of each of which are incorporated in their
entireties.
TECHNICAL FIELD
[0002] The present invention relates to a protector protein Sgo1
(shugoshin) of cohesin Rec8 derived from fission yeast
Schizosaccharomyces pombe, its homologue and paralogue having a
regulatory activity of chromosome segregation, and DNAs encoding
them.
BACKGROUND OF THE INVENTION
[0003] In eukaryotes, sister chromatid cohesion is established
during S phase of cell cycle and. maintained throughout G2 until M
phase. During mitosis, this cohesion is destroyed along the entire
length of chromosome, allowing sister chromatid to segregate to the
opposite sides of cell (equational division) and ensuring that each
daughter cell receives one copy of each chromosome. In contrast,
meiosis consists of two rounds of chromosome segregation following
a single round of DNA replication, leading to the formation of four
haploid gametes from one diploid germ cell. During meiosis I,
homologous chromosomes (homologues) pair to recombine, forming
chiasmata in which one sister chromatid from one homologue is
covalently attached to a sister chromatid from the other homologue.
Hence, in order for homologues to segregate at meiosis I, cohesion
of sister chromatid is necessary to be dissociated along the
chromosome arms to resolve chiasmata. However, sister chromatid
cohesion is retained at centromere until meiosis II, and utilizes
the residual centromeric cohesion when sister chromatid segregates,
in the same manner as it does in mitosis. Thus, meiotic division
requires sister chromatid cohesion to be dissociated in two steps.
However, the molecular mechanism for protection of centromeric
cohesion only during meiosis I and only at the centromere has
remained to be elucidated (e.g., see Annu Rev Genet 35, 673-745
(2001)).
[0004] There are important clues as to the molecular nature of
sister chromatid cohesion, and the mechanism dissociating sister
chromatid cohesion at the onset of anaphase (e.g., see Annu Rev
Genet 35, 673-745 (2001); Curr Opin Cell Biol 12, 297-301 (2000);
Curr Biol 13, R104-14 (2003); Annu Rev Cell Dev Biol 17, 753-77
(2001); Genes Dev 16, 399-414 (2002>>. In various eukaryotes,
sister chromatid cohesion depends on a multisubunit cohesin complex
including Scc1 (Rad21 in fission yeast Schizosaccharomyces pombe).
Anaphase promoting complex (APC)-dependent degradation of the
securin, Cut2/Pds1, allows to dissociate the Cut1/Esp1
endopeptidase (separase), which in turn cleaves Rad21/Scc1,
dissociating sister chromatid cohesion. During meiosis, the
cohesion subunit Rad21/Scc1 is replaced with a meiotic counterpart,
Rec8 (e.g., see Cell 98, 91-103 (1999); Mol. Cell. Biol. 19,
3515-3528 (1999); Nature 400, 461-4 (1999); Genes Dev 15, 1349-60
(2001); J Cell Biol 160, 657-70 (2003)). As Rec8 complex resides
only at centromere after meiosis I and the depletion of Rec8
destroys centromeric cohesion, the presence of Rec8 at centromere
has been thought to confer the persistence of cohesion throughout
meiosis I (e.g., see Nat Cell Biol 1, E125-7 (1999)). Several lines
of evidence suggest that Rec8 along chromosome arms is cleaved by
separase at anaphase I while centromeric Rec8 is specifically
protected until metaphase II (e.g., see Cell 103, 387-98 (2000);
Embo J 22, 5643-53 (2003)). Budding yeast SP013 has been implicated
in the protection of centromeric Rec8 (e.g., see Genes Dev 16,
1659-71 (2002); Genes Dev 16, 1672-81 (2002)), but SP013 is not
centromeric and may function indirectly. Drosophila MEI-S332 is a
protein residing at centromere, is required for the persistence of
centromeric cohesion during meiosis I, and has features of a
candidate protector of meiotic centromeric cohesion, although the
details of such protection have so far not been elucidated (e.g.,
see Annu Rev Cell Dev Biol 17, 753-77 (2001); Cell 83, 247-256
(1995)). Despite the completion of genome sequencing projects on
several organisms, no homologue of these proteins has emerged,
preventing the formulation of .a generalized view of the
protection. Concurrently, studies in fission yeast have illuminated
the importance of pericentromeric heterochromatin for recruiting
centromeric Rec8 complexes and ensuring centromeric cohesion during
meiosis I (e.g., see Science 300, 1152-5 (2003)). However,
pericentromeric heterochromatin cannot alone confer the specific
protection of Rec8 at meiosis I toward meiosis II.
DISCLOSURE OF THE INVENTION
[0005] Almost all the eukaryotes including human propagate
offsprings by sexual reproduction evolutionarily predominant with a
mixture of genome. Meiosis that reduces chromosome number in half
is a core part of the sexual reproduction mechanism. In somatic
mitosis, two kinetochores of sister chromatid are caught by spindle
microtuble extended from the opposite poles, and sister chromatid
is evenly segregated to the both poles by concurrently dissolving
the cohesion of arms and centromeres (equational division). In
contrast, in meiosis I kinetochores of sister chromatids are caught
by spindle microtuble extended from the same pole, and segregated
to the same pole while retaining the cohesion at centromere
(meiotic division). Next, for the first time in meiosis II the
cohesion of centromere site of sister chromatid is dissolved, and
separated toward one pole or the other of the two poles
respectively, which culminates in the generation of accurate four
haploid gametes. Meiosis-specific meiotic division is a modality of
chromosome segregation conserved in almost all the eukaryotes, from
yeast to human, however regulatory mechanism at the molecular level
has remained enigmatic for a long time. The present inventor has
demonstrated that meiosis-specific chromosome cohesion factor,
cohesin plays an essential role in this regulation by using fission
yeast (Nature 400, 461-4 (1999); Science 300, 1152-5 (2003); Nature
409, 359-363 (2001)). An object of the present invention is to
provide meiosis-specific novel kinetochore protein Sgo1 (shugoshin)
derived from fission yeast Schizosaccharomyces pombe, and a
homologue or paralogue thereof having a regulatory activity of
chromosome segregation; and DNAs encoding them; as a factor
ensuring the retention of unidirection and cohesion in sister
centromere at meiosis I in cooperation with cohesin.
[0006] Meiosis comprises two steps of specialized nuclear divisions
for producing haploid gametes. To accomplish this, sister chromatid
cohesion is necessary to be dissociated in a stepwise manner, first
from chromosome arms at anaphase I and second from centromeres at
anaphase II. In particular, the factors that protect centromeric
cohesion during meiosis I have heretofore remained undissolved. To
elucidate the proteins protecting Rec8 during anaphase, the present
inventor screened in fission yeast genes for a gene that inhibits
mitotic growth and prevents sister chromatid from the separation at
anaphase, when co-expressed with Rec8. In this approach,
meiosis-specific protein that is a protector of Rec8 in fission
yeast and protects (Shugo) centromeric Rec8 from the degradation at
anaphase I was indentified, and named Sgo1 (Shugoshin, a Japanese
for "guardian spirit"). It was also identified that shugoshin plays
an important role in mitotic chromosome segregation. and then
identified a budding yeast Sg01 homologue and a fission yeast
mitotic paralogue Sgo2. A marginal similarity between Sgo1 and
Drosophila MEI-S332 was identified. and Sgo1 homologue in other
eukaryotes was also identified. Shugoshin-like proteins in animal
cells, which were predicted from the sequence, also have functional
conservation with yeast shugoshin. The present invention has been
thus completed based on this knowledge.
[0007] That is, the present invention relates to (1) a DNA encoding
a following protein (a) or (b): (a) a protein consisting of an
amino acid sequence shown in SEQ ID NO: 2, (b) a protein comprising
an amino acid sequence where one or several amino acids are
deleted. replaced or added in an amino acid sequence shown in SEQ
ID NO: 2, and having a regulatory activity of chromosome
segregation; (2) a DNA consisting of a base sequence shown in SEQ
ID NO: 1 or a complementary sequence thereof; (3) a DNA containing
part or whole of a base sequence shown in SEQ ID NO: 1 or a
complementary sequence thereof, and encoding a protein that has a
regulatory activity of chromosome segregation; (4) a DNA
hybridizing with the DNA according to "2" under stringent
conditions and encoding a protein that has a regulatory activity of
chromosome segregation; (5) a protein consisting of an amino acid
sequence shown in SEQ ID NO: 2; and (6) a protein consisting of an
amino acid sequence where one or several amino acids are deleted,
replaced or added in an amino acid sequence shown in SEQ ID NO: 2,
and having a regulatory activity of chromosome segregation.
[0008] The present invention also relates to (7) a DNA encoding a
following protein (a) or (b): (a) a protein consisting of an amino
acid sequence shown in SEQ ID NO: 4, (b) a protein consisting of an
amino acid sequence where one or several amino acids are deleted,
replaced or added in an amino acid sequence shown in SEQ ID NO: 4,
and having a regulatory activity of chromosome segregation; (8) a
DNA consisting of a base sequence shown in SEQ ID NO: 3 or a
complementary sequence thereof; (9) a DNA containing part or whole
of a base sequence shown in SEQ ID NO: 3 or a complementary
sequence thereof, and encoding a protein that has a regulatory
activity of chromosome segregation; (10) a DNA hybridizing with the
DNA according to "8" under stringent conditions and encoding a
protein that has a regulatory activity of chromosome segregation;
(11) a protein consisting of an amino acid sequence shown in SEQ ID
NO: 4; and (12) a protein consisting of an amino acid sequence
where one or several amino acids are deleted, replaced or added in
an amino acid sequence shown in SEQ 10 NO: 4, and having a
regulatory activity of chromosome segregation.
[0009] The present invention further relates to (13) a DNA encoding
a following protein (a) or (b): (a) a protein consisting of an
amino acid sequence shown in SEQ ID NO: 6, (b) a protein consisting
of an amino acid sequence where one or several amino acids are
deleted, replaced or added in an amino acid sequence shown in SEQ
ID NO: 6, and having a regulatory activity of chromosome
segregation; (14) a DNA consisting of a base sequence shown in SEQ
ID NO: 5 or a complementary sequence thereof; (15) a DNA containing
part or whole of a base sequence shown in SEQ ID NO: 5 or a
complementary sequence thereof, and encoding a protein that has a
regulatory activity of chromosome segregation; (16) a DNA
hybridizing with the DNA according to "14" under stringent
conditions and encoding a protein that has a regulatory activity of
chromosome segregation; (17) a protein consisting of an amino acid
sequence shown in SEQ ID NO: 6; and (18) a protein consisting of an
amino acid sequence where one or several amino acids are deleted,
replaced or added in an amino acid sequence shown in SEQ ID NO: 6,
and having a regulatory activity of chromosome segregation.
[0010] The present invention still further relates to (19) a DNA
encoding a following protein (a) or (b) that has a regulatory
activity of chromosome segregation: (a) a protein consisting of an
amino acid sequence shown in SEQ ID NO: 8, 10, 12, 14, 16, 18 or
20, (b) a protein consisting of an amino acid sequence where one or
several amino acids are deleted, replaced or added in an amino acid
sequence shown in SEQ ID NO: 8, 10, 12, 14, 16, 18 or 20; (20) a
DNA consisting of a base sequence shown in SEQ ID NO: 7, 9, 11, 13,
15, 17 or 19 or a complementary sequence thereof, and encoding a
protein that has a regulatory activity of chromosome segregation;
(21) a DNA containing part or whole of a base sequence shown in SEQ
ID NO: 7, 9, 11, 13, 15, 17 or 19 or a complementary sequence
thereof, and encoding a protein that has a regulatory activity of
chromosome segregation; (22) a DNA hybridizing with the DNA
according to "7", "9", "11", "13", "15", "17" or "19" under
stringent conditions and encoding a protein that has a regulatory
activity of chromosome segregation; (23) a protein consisting of an
amino acid sequence shown in SEQ ID NO: 8, 10, 12, 14, 16, 18 or
20, and having a regulatory activity of chromosome segregation; and
(24) a protein consisting of an amino acid sequence where one or
several amino acids are deleted, replaced or added in an amino
amino acid sequence shown in SEQ ID NO: 8, 10, 12, 14, 16, 18 or
20, and having a regulatory activity of chromosome segregation.
[0011] Furthermore, the present invention relates to (25) a fusion
protein in which the protein according to "5", "6", "11", "12",
"23" or "24" is bound with a marker protein and/or a peptide tag;
(26) an antibody specifically binding to the protein according to
"5". "6", "11", "12", "23" or "24"; and (27) the antibody according
to "26", which is a monoclonal antibody.
BRIEF DESCRIPTION OF DRAWINGS
[0012] FIG. 1 is a set of pictures showing that sister chromatids
are not segregated during mitosis by co-expression of Sgo1 and Rec8
in the present invention. a.) The cen2-GFP strains expressing the
genes indicated by endogenous promoters (a constitutive chromatin
promoter for rad21+ or rec8+, and a thiamine-repressible promoter
Pnmt1 for Sgo1+) were streaked on a thiamine-depleted plate. b.)
Samples of Padh1-rec8+Pnmt1-sgo1+ cells cultured for 15 hours at
30.degree. C. after thiamine depletion. The non-segregation of
cen2-GFP (asterisk) was identified in the septate junction cells.
c.) The non-segregations of cen2-GFP were counted (n>100). d.)
The Padh1-rec8+-GFP strains were cultured with or without the use
of Pnmt1-sgo1+ in the same manner as (b). Samples of cells at
interphase and anaphase are shown.
[0013] FIG. 2 is a set of pictures showing that sister chromatid
segregation was undergone in mitosis by expression of non-cleavable
Rec8. The plasmid pREP41-rec8-RDRD (expressing non-cleavable Rec8
(Embo J 22, 5643-53 (2003))) was integrated into the chromosome of
cen2-GFP cell strains (+Rec8-RDRD), and the cells were streaked on
plates with or without the presence of thiamine. The host strain
cells (-Rec8-RDRD) were similarly cultured as a control. Note that
Rec8-RDRD is expressed only on the thiamine-free plate. Samples of
cells cultured in culture medium for 15 hours at 30.degree. C.
after the depletion of thiamine.
[0014] FIG. 3 is a set of pictures showing that sgo1 of the present
invention is required to protect Rec8 and thereby cohesion at
centromeres arises during anaphase of meiosis I. a.) As for one of
the homologues marked with cen2-GFP, segregation during meiosis was
observed in wild-type and sgo1.DELTA. cells (n>170). A normal
segregation pattern of cen2-GFP is illustrated (left). Samples of
sgo1.DELTA. cells are shown (right). b.) Separation of sister
cen2-GFP dots after meiosis I (mes1.DELTA.arrest) is evident in
sgo1.DELTA. cells. c.) The Rec8-GFP signal was observed in the
indicated cells at late anaphase I (n>30) and at prometaphase II
(n>100), and the frequency of centromeric Rec8-GFP displayed in
the cells was counted. The spindles were visualized by expressing
CFP-Atb2 (a2-tubulin) (Curr Biol 11, 836-45 (2001)). d.) Rec8-GFP
levels throughout the indicated chromosome sites in the arrested
cells were measured prior to meiosis I (mei4.DELTA. arrest) by ChIP
assay with the use of anti-GFP antibodies. The bottom panel shows
Schizosaccharomyces pombe chromosome I schematically, and the
primers (cnt, imr, dg, dh, lys1, mes1) were used there.
[0015] FIG. 4 is a set of pictures showing that Sgo1 of the present
invention localizes at pericentromeric regions during meiosis I.
a.) Synchronous meiosis of diploid pat1-114/pat1-114 cell strains
(Embo J 22, 5643-53 (2003)) was sampled, meiotic nuclear division
was monitored by DAPI staining, and the protein level of Sgo1 was
detected by Western blotting with the use of anti-Sgo1 antibodies.
b.) Sgo1 (green) was counterstained with tubulin (red) and DAPI
(4'6'-diamidino-2-phenylindole) (blue) at the indicated stages in
meiotic cells. c.) A sgo1+-GFP cell co-expressing mis6+-CFP was
examined under fluorescence microscopy. Sgo1-GFP (green) and
Mis6-CFP (red) are merged. d.) Sgo1-GFP levels throughout the
indicated chromosome sites in cells arrested at metaphase I were
measured by ChIP assay with the use of anti-GFP antibodies. The
same primers as for FIG. 2d in synchronism with additional primers
at mat (heterochromatin region at the mating type locus) and TAS
(telomere associated sequence) were used. e.) Sgo1-GFP (green) was
detected at metaphase I in the indicated cells that express CFP
Atb2 to visualize spindles (red). f.) Rec8-HA was expressed with or
without Sgo1-FLAG in proliferating cells, and the extracts were
immunoprecipitated with anti-FLAG antibody. g.) A model for the
action of shugoshin in meiosis. Shugoshin protects centromeric Rec8
complexes from cleaving by separase at the onset of anaphase I,
thereby preserves the centromeric cohesion until meiosis II.
Shugoshin is degraded depending on APC during anaphase II.
[0016] FIG. 5 is a set of pictures showing the time-dependent
change of the expression levels of Sgo1 and Rec8 in synchronous
culture of haploid pat1-114 cell strains (wt), and of cut1-206 or
Prad21-slp1 cells. The expression of slp1+ (a fission yeast CDC20
homologue required for APC activation (Mol Cell Biol 17, 742-50
(1997))) was repressed during meiosis in Prad21-slp1 cells where
slp1 promoter was replaced with rad21. Meiotic nuclear division was
monitored by DAPI staining, and the protein levels of Sgo1, Rec8,
and tubulin (control) were measured by western blotting with the
use of anti-Sgo1, anti-Rec8 and anti-tubulin antibodies,
respectively. Although cut1-206 cells together with normal kinetics
led to Sgo1 degradation, Rec8 degradation was delayed. Prad21-slp1
cells showed delayed degradation of Sgo1 as well as Rec8.
Arrowheads indicate a cleavage product of Rec8 by separase
Cut1.
[0017] FIG. 6 is a set of pictures showing that ectopic expression
of sgo1+ inhibits the growth of the cut1-206 mutant. Chromosomal
sgo1+ promoter was replaced with Pnmt1 or Pnmt41 (a weaker version
of Pnmt1), and the effect on the mitotic growth in cut1-206
temperature-sensitive cells was examined. The indicated cells were
streaked on a plate without thiamine and cultured for 3 days at
28.degree. C. The cut1-206 cells moderately expressing Sgo1 by
Pnmt1, arrested mitotic growth even at the permissive temperature,
whereas cut1+ cells grew normally.
[0018] FIG. 7 is a set of pictures showing that Sgo2 of the present
invention plays an important role in mitotic at centromere. a.)
Serial dilutions of the indicated cultures were spotted onto YEA
plates containing 0, 5 or 10 .mu.g/ml of TBZ, and cultured for 3
days at 30.degree. C. b.) The indicated strains were streaked on
YEA plates and cultured for 3 days at 30.degree. C. c.) Sgo2-GFP
(green) was detected at anaphase I in wild-types and in bub1.DELTA.
cells that express CFP-Atb2 to visualize spindles (red). DNA was
stained with Hoechst (blue). Wild-type cells at anaphase are also
shown. d.) The sgo2+-GFP mis6+-HA cells were fixed and stained with
anti-GFP and anti-HA antibodies. e.) Sgo2-GFP levels were measured
throughout the indicated chromosome sites in cells arrested at
prometaphase or in asynchronous cells by ChIP assay.
[0019] FIG. 8 is a set of pictures showing the results of analysis
of budding yeast shugoshin ScSgo1 of the present invention. a.)
Budding yeast ScSGO1-GFP diploids in proliferation were fixed with
methanol and counterstained with DAPI. b.) ScSGO1-Myc NDC10-HA
cells were fixed, and stained with DAPI and antibodies against Myc
and HA. c.) ScSGO1-GFP diploids causing meiosis in culture medium
were fixed with methanol and counterstained with DAPI. d.) Serial
dilutions of the indicated cultures were spotted onto YPD plates
containing 0 or 15 .mu.g/ml of benomyl. e.) Chromosome loss was
analyzed in wild-types (wt) and Scsgo1.DELTA. mutants by a colony
sectoring assay. The loss of nonessential chromosome fragments
resulted in a red sector in a white colony. As a positive control,
ubr1.DELTA. mutant was used (Nature 410, 955-9 (2001)). The
frequency of sectoring colonies is shown at the bottom (n>120).
f.) Samples of segregation of cenV-GFP in Scsgo1.DELTA. tetrads.
The segregation patterns in tetrads were mostly classified as one
of the three shown at the bottom. The each population (n=200) is
also shown. g.) ScSGO1-Myc diploids were induced by synchronous
meiosis and were examined the segregation of cenV-GFP marked on one
of two homologues at meiosis I and meiosis II. Although most of the
cells caused reductional segregation pattern at meiosis I (96%,
n=207), the incidence of non-segregation was high at meiosis II
(34%, n=322). h.) The cells marked with cenV-GFP on both homologues
were induced to meiosis, and counterstained with anti-tubulin
antibody and DAPI. Cells at late anaphase I were examined for
cenV-GFP dots. ScSGO1-Myc cells frequently showed split cenV-GFP
dots at either pair of sister chromatids (72%, n=138), while
control wild-type cells did not (<2%, n=106).
[0020] FIG. 9 is a set of pictures showing sequences of the amino
terminal coiled-coil regions and carboxyl terminal basic regions of
shugoshin-like proteins in various organisms. The primary sequences
of the amino terminal regions of Sgo1 are conserved in
Schizosaccharomyces pombe (Sgo1 and Sgo2), budding yeast (ScSgo1)
and Neurospora crassa (B23G1.060), while the sequences containing
ME1-S332 in other species are not conserved, all presumably carry
coiled-coil motif (predicted by COILS program (Science 252, 1162-4
(1991))). See the arrowheads, asterisks and circles in the
pictures. The sequences in FIG. 9 respectively correspond to the
following SEQ ID NOs: Sg01_Sp18: SEQ ID NO: 21; Sg02_Sp10: SEQ ID
NO: 22; Sg01_Sc40: SEQ ID NO:23; B23GI.060_Nc19: SEQ ID NO: 24;
Mei-S332_Dm2: SEQ ID NO: 25; Sg01_Sp277: SEQ ID NO: 26; Sg01_Sp569:
SEQ ID NO: 27; Sg01_Sc364: SEQ ID NO: 28; B23GI.060_Nc464: SEQ ID
NO: 29; Mei-S332_Dm367: SEQ ID NO: 30; C33H5.15_Ce: SEQ ID NO: 31;
AT3G10440.1_At: SEQ ID NO: 32; AT5G04320.1_At: SEQ ID NO: 33;
BAB29295.1_Mm: SEQ ID NO: 34; Tripin_Mm: SEQ ID NO:35; Q9BVA8_Hs:
SEQ ID NO: 36; Tripin_Hs: SEQ ID NO: 37.
[0021] FIG. 10 is a picture showing the results of examination of
sgo1 mutations that were generated within conserved regions. Both
h+sgo1.DELTA. and h-sgo1.DELTA.cen2-GFP cells transformed with the
indicated plasmid, were mixed on SPA plates and monitored for
segregation of cen2-GFP at miosis II. A plasmid pREP81 bearing a
weak version of the thiamine-repressible nmt1 promoter was used to
express sgo1. Control cells carrying plasmid pREP81-sgo1 (wt)
showed nearly 80% the segregation at meiosis II, whereas cells
expressing non-segregation sgo1 allele showed random segregation
(50% segregation). Any of the mutations tested, except a
non-conserved site mutation 297TA, did not complement sgo1.DELTA.
in this assay. The means of two independent experiments are shown
(n>100).
[0022] FIG. 11 (a) is a picture showing schematic representation of
the shugoshin family proteins. A predicted coiled-coil (red) and a
conserved basic region (blue) exist in the N-terminal and
C-terminal regions respectively. Further, FIG. 11 (b) is a picture
showing the result of analysis in HeLa cell extracts by western
blotting after transfection with siRNA.
[0023] FIG. 12 is a set of pictures showing the results that HeLa
cells were stained (green) with antibody against hSgo1 or hSgo2
prepared from rabbit, concurrently stained with tubulin antibody
and DAPI, and then respectively co-stained with spindle (red) and
chromosome DNA (blue). Meanwhile, the cells were fixed with
paraformaldehyde.
[0024] FIG. 13 is a set of pictures showing the results that HeLa
cells at prometaphase and metaphase were stained with antibodies
against hsgo1 or hSgo2 (green), and concurrently co-stained with
antibodies against centromere protein CENP-A (a, c; red),
antibodies against passenger protein Aurora B of chromosome
localized within kinetochore from prophase to metaphase (b, d;
red), and DAPI (blue). Both signals of hSgo1 and hSgo2 showed
signals at the sites close to CENP-A dots on chromosome. From the
above, it was revealed that both hsgo1 and hSgo2 are centromere
proteins. Furthermore, both sites of Sgo1 and Aurora B were
practically the same at prometaphase and metaphase, whereas Sgo2
was placed just outside Aurora B. From the above, it was revealed
that both hsgo1 and hSgo2 are placed within kinetochore from
prometaphase to metaphase.
[0025] FIG. 14 is a picture showing the results of RNAi experiments
that targeted hsgo1 and hSgo2 respectively. The expressions in any
proteins were significantly suppressed after 48 hours, thereby the
cells arrested in mitosis (total in the figure) were accumulated.
As the accumulation was dissolved by suppressing a spindle
checkpoint factor BubR1 by RNAi, it was suggested that hSgo1 and
hSgo2 directly or indirectly function during the process where
spindle take kinetochore properly at centromeres.
[0026] FIG. 15 is a set of pictures showing the results, where RNAi
experiments targeting hsgo1 was performed by using HeLa cells, and
then the cells were mounted on a slide glass and stained with
Giemsa. It was revealed that sister chromatid strongly adhered at
centromere site in control cells; but in cells suppressed hsgo1,
the adhesion at centromere site was weak, and easily detached by
the experiment operation.
[0027] FIG. 16 is a set of pictures showing that Sgo1 and Bub1 are
required for condensation at centromeres in mitosis. (a) By
treatments with siRNA, chromosome spread was performed in mitotic
HeLa cells stained with Giemsa. Representative spread is shown
together with the occurrence rates. More than one hundred of the
prophases and prometaphases were observed for each RNAi. An example
of sister chromatid pair is magnified at the top. (b) After
treatment with nocodazole for 4 hours, chromosome spread was
observed in cells interfered with RNAi. Examples of the spread are
shown with the frequency (n>100). (c) HeLa cells expressing
Scc1-myc were fixed at 36 hours after the treatment with siRNAs.
The cells were immunostained with anti-myc-antibody (green) and
anti-centromere-antibody (ACA) (red). DNA was stained with DAPI
(blue). (d) Rates of the cells showing Scc1-myc staining are shown.
Cells expressing Scc1-myc in this cell line were less than 25%.
Scale bar shows 10 .mu.m.
[0028] FIG. 17 is a set of pictures showing the results of RNAi
experiments targeting Bub1, respectively. (A, B) RNAi experiments
targeting Bub1 were performed respectively, and resulted in
disappearance of the localization of both proteins, hSgo1 and hSgo2
at centromere. (C, D) As the localization of both proteins, hSgo1
and hSgo2 at centromere was normal in RNAi experiments targeting a
control, BubR1; the significance of the results of Bub1 was
ensured. It is shown that Bub1 and BubR1 are similar but different
proteins, and the localization of hSgo1 and hSgo2 at centromere
depends on Bub1 (A, B), but not on BubR1 (C, D).
[0029] FIG. 18 is a set of pictures showing the results that a
clone in which cDNA of mouse shugoshin homologous gene (SEQ ID NOs:
21 and 23) is fused with GFP gene was generated by using retroviral
vector, and expressed in human HeLa cells. It was revealed that any
of the GFP fusion proteins is co-localized with human kinetochore
protein Bub1 in mitosis. The appended drawings of the figures are
presented to further describe the invention and to assist in its
understanding through clarification of its various aspects.
BEST MODE OF CARRYING OUT THE INVENTION
[0030] As for a protein of the present invention, a protein Sgo1
(shugoshin) comprising an amino acid sequence shown in SEQ ID NO: 2
and having a regulatory activity of chromosome segregation; a
protein comprising the amino acid sequence shown in SEQ ID NO: 2
where one or several amino acids are deleted, replaced or added,
and having a regulatory activity of chromosome segregation; a
paralogue Sgo2 of protein Sgo1 comprising an amino acid sequence
shown in SEQ ID NO: 4 and having a regulatory activity of
chromosome segregation; a protein comprising the amino acid
sequence shown in SEQ ID NO: 4 where one or several amino acids are
deleted, replaced or added, and having a regulatory activity of
chromosome segregation; a Saccharomyces cerevisiae homologue ScSgo1
of protein Sgo1 comprising an amino acid sequence shown in SEQ ID
NO: 6 and having a regulatory activity of chromosome segregation; a
protein comprising the amino acid sequence shown in SEQ ID NO: 6
where one or several amino acids are deleted, replaced or added,
and having a regulatory activity of chromosome segregation; a
protein (NC) comprising an amino acid sequence shown in SEQ ID NO:
8 and having a Neurospora crassa-derived regulatory activity of
chromosome segregation; a protein comprising the amino acid
sequence shown in SEQ ID NO: 8 where one or several amino acids are
deleted, replaced or added, and having a regulatory activity of
chromosome segregation; a protein (At) comprising an amino acid
sequence shown in SEQ ID NO: 10 or 12 and having a
Arabidopsis-derived regulatory activity of chromosome segregation;
a protein comprising the amino acid sequence shown in SEQ ID NO: 10
or 12 where one or several amino acids are deleted, replaced or
added, and having a regulatory activity of chromosome segregation;
a protein (Mm) comprising an amino acid sequence shown in SEQ ID
NO: 14 or 16 and having a mouse-derived regulatory activity of
chromosome segregation; a protein comprising the amino acid
sequence shown in SEQ ID NO: 14 or 16 where one or several amino
acids are deleted, replaced or added, and having a regulatory
activity of chromosome segregation; a protein (Hs) comprising an
amino acid sequence shown in SEQ ID NO: 18 or 20 and having a
human-derived regulatory activity of chromosome segregation; and a
protein comprising the amino acid sequence shown in SEQ ID NO: 18
or 20 where one or several amino acids are deleted, replaced or
added, and having a regulatory activity of chromosome segregation;
can be exemplified. Further, as for the regulatory activity of
chromosome segregation described in the above, although it is not
especially limited as long as the activities regulate chromosome
segregation, for example, activities correctly regulating
chromosome segregation of germ cells and/or of somatic cell
division are preferable, and activities protecting (Shugo) the
centromere of sister chromatid from the separation in meiosis I is
more preferable. In addition, proteins of the present invention can
be prepared by known methods based on DNA-sequence information and
the like, and the derivations are not limited to yeast, mouse,
human and the like. Furthermore, for example, Sgo1 (shugoshin)
mutant that is a protein comprising an amino acid sequence shown in
SEQ ID NO: 2 where one or several amino acids are deleted, replaced
or added, and having a regulatory activity of chromosome
segregation, can be prepared by ordinary methods such as known gene
manipulation, point mutation and the like.
[0031] As for a DNA of the present invention, a DNA encoding a
protein of the present invention that has a regulatory activity of
chromosome segregation: a DNA derived from fission yeast
Schizosaccharomyces pombe, comprising a base sequence shown in SEQ
ID NO: 1 or 3 or a complementary sequence thereof; and a DNA
containing part or whole of these sequences, encoding a protein
that has a regulatory activity of chromosome segregation: a DNA
derived from Saccharomyces cerevisiae, comprising a base sequence
shown in SEQ ID NO: 5 or a complementary sequence thereof; and a
DNA containing part or whole of these sequences, encoding a protein
that has a regulatory activity of chromosome segregation: a DNA
derived from Neurospora crassa, comprising a base sequence shown in
SEQ ID NO: 7 or a complementary sequence thereof, and encoding a
protein that has a regulatory activity of chromosome segregation;
and a DNA containing part or whole of these sequences, encoding a
protein that has a regulatory activity of chromosome segregation: a
DNA derived from Arabidopsis, comprising a base sequence shown in
SEQ ID NO: 9 or 11 or a complementary sequence thereof, and
encoding a protein that has a regulatory activity of chromosome
segregation; and a DNA containing part or whole of these sequences,
encoding a protein that has a regulatory activity of chromosome
segregation: a DNA derived from mouse, comprising a base sequence
shown in SEQ ID NO: 13 or 15 or a complementary sequence thereof,
and encoding a protein that has a regulatory activity of chromosome
segregation; and a DNA containing part or whole of these sequences,
encoding a protein that has a regulatory activity of chromosome
segregation: a DNA derived from human, comprising a base sequence
shown in SEQ ID NO: 17 or 19 or a complementary sequence thereof,
and encoding a protein that has a regulatory activity of chromosome
segregation; and a DNA containing part or whole of these sequences,
encoding a protein that has a regulatory activity of chromosome
segregation: a DNA hybridizing with the above DNA under stringent
conditions, encoding a protein that has a regulatory activity of
chromosome segregation: and the like, can be exemplified.
[0032] These DNAs can be prepared by known methods based on
DNA-sequence information, such as a gene or cDNA library of yeast,
mouse, human and the like. Further, using a base sequence shown in
SEQ ID NO: 1, 3, 5, 7, 9, 11, 13, 15, 17, 19, or others or a
complementary sequence thereof, or part or whole of these sequences
as a probe, DNA libraries of yeast, mouse, human and the like are
hybridized under stringent conditions, and the intended DNA
encoding a protein that has a regulatory activity of chromosome
segregation can be obtained by isolating the DNAs that hybridized
with the probes. As for a condition of hybridization to obtain the
DNA; hybridization at 42.degree. C., and washing treatment by a
buffer containing 1.times.SSC and 0.1% SDS at 42.degree. C.;
preferably hybridization at 65.degree. C., and washing treatment by
a buffer containing 0.1.times.SSC and 0.1% SDS at 65.degree. C.;
can be exemplified. Moreover, as for an element affecting the
stringency of hybridization, there are various elements other than
the above described temperature conditions, those skilled in the
art can actualize the stringency equivalent to that of
hybridization as exemplified in the above with an appropriate
combination of various elements.
[0033] As for a fusion protein of the present invention, any
protein can be used as long as the protein of the present invention
is bound to a marker protein and/or a peptide tag, as for a marker
protein, it is not especially limited but a conventionally known
marker protein, for example, alkaline phosphatase, Fc region of
antibody, HRP, GFP and the like can be exemplified. Further, as for
a peptide tag of the present invention, conventionally known
peptide tags such as Myc, His, FLAG and GST tags can be
specifically exemplified. The fusion protein can be produced by
ordinary methods; and is useful for purification of protein Sgo1
and the like by using the affinity of Ni-NTA and His tag, and for a
reagent for study in the art.
[0034] As for an antibody specifically binding to a protein of the
present invention, immunospecific antibodies such as monoclonal
antibody, polyclonal antibody, chimeric antibody, single-stranded
antibody, humanized antibody and the like, can be specifically
exemplified. These antibodies can be produced by ordinary methods
with the use of proteins such as the above-mentioned Sgo1 or part
thereof as an antigen, and among them a monoclonal antibody is
preferable in terms of specificity. Antibodies such as a monoclonal
antibody are useful for elucidating the localization of Sgo1 and
others in vivo.
[0035] The above-mentioned antibodies of the present invention can
be generated with the use of common protocol by administering
proteins of the present invention or fragments containing epitope
thereof, or cells expressing the protein on their membrane
surfaces, to animals (preferably non-human). For example, for
preparation of a monoclonal antibody any method such as hybridoma
(Nature 256, 495-497, 1975), trioma, human B cell hybridoma
(Immunology Today 4, 72, 1983) and EBV-hybridoma (MONOCLONAL
ANTIBODIES AND CANCER THERAPY, pp. 77-96, Alan R. Liss, Inc.,
1985), by which antibodies are generated from cultures of
continuous cell lines, can be used.
[0036] To generate a single-stranded antibody against a protein of
the present invention, a method for preparation of single-stranded
antibody (U.S. Pat. No. 4,946,778) can be applied. Further, to
express a humanized antibody, transgenic mouse or other mammals can
be used, clones that express a protein of the present invention
with the use of the above-mentioned antibody can be
isolated/identified, and its polypeptide can be purified by
affinity chromatography. Antibodies against peptide containing
proteins of the present invention or antigen epitopes thereof can
be possibly used for diagnosis and treatment of cancer, or of
chromosome segregation diseases such as infertility or Down's
syndrome using a regulatory factor of chromosome segregation as an
index.
[0037] Functional analysis of a protein of the present invention
can be performed by using fusion proteins fused with, for example;
fluorescent substances such as FITC (fluorescein isocyanate) or
tetramethyl rhodamine isocyanate; radioisotopes such as 125I, 32P,
14C, 35S or 3H; labelings with enzymes such as alkaline
phosphatase, peroxidase, .beta.-galactosidase or phycoerythrin;
fluorescence emission proteins such as green fluorescent protein
(GFP); or the like, to antibodies such as the above-mentioned
monoclonal antibodies. As an immunological assay method with the
use of antibody of the present invention, methods such as RIA,
ELISA, Fluorescent antibody method, Plaque forming cell assay,
Spotting method, Hemagglutination testing, Ouchterlony method can
be exemplified.
[0038] The present invention will be explained in detail in the
following by referring to the examples, but the technical scope of
the present invention will not be limited to these.
Example 1
Method
(Screening of Rec8 Protector)
[0039] The present inventor examined a gene that is toxic only when
co-expressed with Rec8 in vegetative cells. The Rec8 encoding
sequence that was fused with GFP was cloned into pREP82 (ura4+
marker) under the thiamine-repressible nmt1+ promoter, to construct
pREP82-rec8+-GFP. A Schizosaccharomyces pombe cDNA library
constructed by mRNA that was prepared from meiotic cells, and a
pREP3 vector (nmt1+ promoter, LEU2+ marker) (Y. Akiyoshi and Y. W.,
unpublished) were used. The leu1 ura4-D18 cells carrying
pREP82-rec8+-GFP were transformed with the cDNA library, spread on
agar plates containing thiamine (promoter-off) and incubated for 3
days at 30.degree. C. The colonies were then replicated on two
thiamine-free agar plates: one that contains uracil and
5'-fluoroortoic acid (5'-FOA) where only cells lacked the plasmid
pREP82-rec8+-CFP can grow (thereby expresses a library clone
alone), and the other that does not contain 5'-FOA (allows
co-expression of rec8+-GFP and a library clone). The present
inventor added Phloxine B, a drug that stains dead cells red, onto
the both agar plates, thereby illuminated sick colonies. After
incubation for two days, the colonies exhibiting sickness only on
the co-expression agar plate were picked up, and the
library-derived plasmids were recovered and analyzed.
(Schizosaccharomyces pombe Strains)
[0040] Deletion and tagging of GFP or FLAG to endogenous sgo1+ and
sgo2+ were performed by a PCR-based gene targeting method (Yeast
14, 943-951 (1998)). By inserting GFP into the C-terminus of the
PCR-amplified sgo1+-FLAG, sgo1+-FLAG-GFP was generated and
integrated into the endogenous sgo1 locus. Further, a endogenous
promoter of the sgo1+ was replaced with a nmt promoter to generate
Pnmt-sgo1+ or Pnmt-sgo1+-FLAG-GFP by the PCR-based gene targeting
method. The proteins tagged to Sgo1-GFP or Sgo1-FLAG was deleted
depending on the purpose. A mei4.DELTA. mutation was used to arrest
meiotic cells prior to meiosis I (close to late prophase in meiosis
I), and a mes1 .DELTA. mutation was used to arrest after meiosis I,
as described previously (Nature 400, 461-4 (1999)).
(Observation of Chromosomes Marked with GFP)
[0041] To observe the segregation patterns of homologues at meiosis
I, h90 cells retaining cen2-GFP (Embo J 22, 2284-96 (2003)) were
spotted on meiosis-inducing medium, SPA. To examine the segregation
patterns of sister chromatids, opposite mating type cells, one
marked with cen2-GFP and the other not marked, were mixed and
spotted on SPA. After incubation for one day, the zygotes were
monitored for GFP. Images were obtained under a microscope
(Axioplan2, Zeiss) equipped with a cooled CCD camera (Quantix,
Photometrics) and by using Metamorph software (Universal Imaging
Corporation). Seven Z-sections for GFP signals were converted to
single two-dimensional images by taking the maximum signal at each
pixel position in the images.
(Chromatin Immunoprecipitation; ChIp)
[0042] Diploid sgo1+-FLAG-GFP was used for ChIP with Sgo1. To
achieve a highly synchronous culture, the endogenous slp1+ promoter
was replaced with the rad21+ promoter that is not active during
meiosis, and the cells were arrested at metaphase I. The cells were
incubated in nitrogen-depleted medium for 17 hours at 30.degree.
C., and 60% the cells or less were arrested at metaphase I. For
ChIP with Sgo2, nda3-KM311 sgo2+-GFP cells were proliferated at
30.degree. C., and then shifted to 18.degree. C. After incubation
for 8 hours, most of the cells were arrested at metaphase. The
cells were fixed with 3% para-formaldehyde for 30 minutes at
18.degree. C., and extracts were prepared. The DNA was broken to an
average size of 400 bp, and the extracts were immunoprecipitated
with rabbit anti-GFP antibodies (Clontech). DNAs prepared from the
whole cell crude extracts, or immunoprecipitated chromatin
fractions were analyzed by quantitative PCR, with a LightCycler or
a Lightcycler-DNA Master SYBR Green I kit (Roche Molecular
Biochemicals). Antibody-minus samples were used as controls in each
experiment to explain the nonspecific binding in the ChIP
fractions.
(Preparation of Anti-Sgo1 Antibodies)
[0043] Sgo1+ ORF was PCR-amplified from an Schizosaccharomyces
pombe cDNA library, and inserted into plasmids pGEX4T-2 (Pharmacia
Biotech) and pET-19b (Novagen) respectively to prepare recombinant
proteins GST-Sgo1 and His-Sgo1. GST-Sgo1 was used to immunize
rabbit, and the raised antibodies were purified by His-Sgo1 as
described previously (Embo J 22, 5643-53 (2003)). Furthermore, for
the purpose of analyzing proteins (SEQ ID NOs: 18 and 20; hSgo1 and
hSgo2 respectively) encoding human shugoshin homologous gene (SEQ
ID NOs: 17 and 19), part of hSgo1 and hSgo2 was expressed in E
coli, and antibodies against hSgo1 and hSgo2 were produced by
injecting the protein into rabbit.
(Immunostaining)
[0044] To stain endogenous Sgo1, wild-type diploid cells cultured
for 5 hours in MM-N were fixed with 3% formaldehyde for 40 min at
30.degree. C., and stained by the method described previously (Embo
J 22, 5643-53 (2003)). To stain Sgo2-GFP and Mis6-HA,
logarithmically growing cells were used. Sgo1 was detected by using
rabbit anti-Sgo1 antibody at 1:50 and Alexa488-conjugated
anti-rabbit antibody (Molecular Probes) at 1:100. Tubulin was
detected by using mouse anti-tubulin antibody TAT-1 (provided by
Keith Gull) at 1:200 and Cy3-tagged anti-mouse antibody (Chemicon)
at 1:2000. Cells were counterstained with DAPI to visualize DNA.
The Sgo2-GFP was detected by using mouse anti-GFP antibody (Roche)
at 1:50 and BODIPY FL-conjugated anti-mouse antibody (Molecular
Probes) at 1:100. The Mis6-HA was detected by using rabbit anti-HA
antibody Y-11 (Santa Cruz) at 1:50 and Alexa488-conjugated
anti-rabbit antibody at 1:100. Cells were counterstained with DAPI
to visualize DNA. Further, immunostaining was performed by using
rabbit anti-hSgo1 antibody and rabbit anti-hSgo2 antibody in the
same manner as the above.
(Communoprecipitation)
[0045] Padh-rec8+-3HA Pnmt41-sgo1+-FLAG-GFP strain cells and
control Padh-rec8+-3HA strain cells were cultured without thiamine
for 15 hours at 30.degree. C., collected, and the extracts were
prepared. To liberate chromatin-bound proteins, the extracts were
treated with DNase I. After clarifying the extracts by
centrifugation, the Sgo1-FLAG-GFP protein was immunoprecipitated
with anti-FLAG antibody M2 (Sigma). The Rec8-3HA and Sgo1-FLAG-GFP
were detected by anti-HA antibody Y-11 and anti-FLAG antibody M2,
respectively.
(Analysis of Budding Yeast)
[0046] All sample strains except those for chromosome loss assay
are derivative of SK1 (Cell 98, 91-103 (1999)). The chromosome loss
assay was performed as described previously (Nature 410, 955-9
(2001)). The ScSGO1 gene was deleted or epitope-tagged by using PCR
generated cassettes (Yeast 14, 953-961 (1998)). Accurate gene
targeting was checked by PCR. URA3-GFP dots marking chromosome V
(cenV-GFP) were described previously (Cell 98, 91-103 (1999)).
Sporulation was induced by culturing diploid cells at 30.degree. C.
as described previously (Dev Cell 4, 535-48 (2003)). In situ
immunofluorescence was performed as described previously (Dev Cell
4, 535-48 (2003)).
(Cell Culture)
[0047] HeLa cells were cultured in DMEM supplemented with 10% fetal
bovine serum and 0.03% L-Glutamine. The HeLa cell strain expressing
Scc1-myc was cultured with 200 .mu.g/ml of G418 (Invitrogen) and
100 .mu.g/ml of Hygromycin B (Wako). Expression of Scc1-myc was
induced by incubation with 2 .mu.g/ml of Doxycyclin (Sigma) for 48
hours.
(Preparation of Anti-Human Sgo Antibody)
[0048] As the information for N-terminal amino acid sequence of
human Sgo1 was not obtained from the databases, the present
inventor cloned a cDNA fragment that was amplified from a cDNA
library (BD Biosciences) with the use of primers recognizing the
cloning site of .lamda.TriplEx: CTCGGGAAGCGCGCCATTGTG (SEQ ID NO:
38) and the DNA sequence corresponding to the numbers 237-242 in
amino acid sequence of Q9BVA8: CCTGGCTGAATCAGCTTTGGTG (SEQ ID NO:
39). The Sequencing revealed that the Sgo1 mRNA encodes a protein
having 527 amino acids. To obtain polyclonal antibodies against
Sgo1, a cDNA fragment encoding the numbers 109-491 in amino acid
sequence of Sgo1 was amplified and inserted into the reading frames
of plasmids pGEX4T-2 (Amersham) and pET19b (Novagen) to produce
GST-Sgo1 and His-Sgo1 respectively, and followed by immunization of
a rabbit (QIAGEN) (performed according to the manufacturer's
instructions). His-Sgo1 was affinity-purified on CNBr-activated
sepharose (Amersham). Antibodies against Sgo2 were raised with
GST-Sgo2 (amino acid numbers 331-631) and purified with His-Sgo2 in
the same manner as the above.
(Immunofluorescence Microscopy and Chromosome Spreading)
[0049] Immunofluorescent staining was performed as described in the
above, by using anti-human Sgo1 (1:1000), anti-human Sgo2 antiserum
(1:10000), anti-Bub1 (1:1000, MBL), anti-BubR1 (1:1000, MBL),
anti-CENP-A (1:1000, MBL), anti-Aurora B AIM-1 (1:1000, BD
Biosciences) and anti-tubulin DM1A (1:1000, Sigma). Immunostaining
of Scc1-myc was performed as described in the above, by using
anti-myc CM-100 (1:1000, Gramsch Laboratories) and ACA (1:1000,
provided from Dr. Yoshinari Takasaki). As a secondary antibody,
Alexa Fluor 488 goat anti-rabbit antibody (1:1000, Molecular
Probes), Cy3 conjugated anti-mouse antibody (1:1000, CHEMICON), and
Cy3 conjugated donkey anti-human antibody (1:1000, Jackson
ImmunoResearch Laboratories. Inc) were used. 3 .mu.g/ml of Hoechst
33342 or 0.5 .mu.g/ml of DAPI were used for counter staining.
Images were taken by using SlideBook or MetaMorph software.
(Chromosome Spreading)
[0050] HeLa cells during mitosis were collected by mitotic
shake-off and incubated with 330 nM of nocodazole for 0 up to 4
hours. Chromosome spreading was performed as described in the
above.
(Immunoblotting)
[0051] HeLa cells were boiled with the sample buffer and resolved
by SDS-polyacrylamide gel electrophoresis. Proteins were
transferred to Immobilon-P membrane (Millipore), followed by
blocking with 5% Skim milk (Nacalai) in TBST (150 mM of NaCl, 20 mM
of Tris-HCl pH7.4, 0.05% Tween-20). Antibody incubations were
performed in 0.1% skim milk TBST supplemented with anti-Sgo1
antibody (1:1000), anti-Sgo2 antibody (1:1000), anti-Bub1 antibody
(1:500) and anti-tubulin antibody (1:3000). Blots were produced by
ECL (Amersham).
(RNAi)
[0052] As a siRNA target sequence, hSgo1: AAGUCUACUGAUAAUGUCUUATT
(SEQ ID NO:40) and hSgo2: AAGCACUACCACUUUGAAUAATT (SEQ ID NO:41),
and human Sgo1: GUGAGCCUCUGUGAAUCAATT (SEQ ID NO:42) and human
Sgo2: GCUCUCAUGAACAAUAACUTT (SEQ ID NO:43) were respectively
selected on hSgo1RNA or hSgo2RNA. Furthermore, as a siRNA target
sequence, GAGUGAUCACGAUUUCUAATT (SEQ ID NO: 44) was selected on
other siRNA target sequence, Bub1 RNA; siRNA target sequence,
AACGGGCAUUUGAAUAUGAAA (SEQ ID NO: 45, see JCS, 117, 1577-1589
(2004)) was selected at 2 sites on a spindle checkpoint factor
BubR1 RNA. These sequences were synthesized as double strand, and
introduced into cells by using oligofectamine (Invitrogen).
Furthermore similarly, when producing HIV vector, HeLa cells were
transfected with HIV plasmid vector, pMD.G (VSV-G env expressing
plasmid), pMDLg/p.RRE (the third generation packaging plasmid) and
pRSV Rev (Rev expressing plasmid) by calcium phosphate method,
collected the culture supernatant 48 hours after the transfection,
and condensed to use as a virus vector.
Example 2
Results
(Identification of Shugoshin Sgo1 in Fission Yeast)
[0053] The replacement of the mitotic cohesin, Rad21/Scc1, with the
meiotic version, Rec8, is a prerequisite for protecting centromeric
sister chromatid cohesion through anaphase of meiosis I ((Cell 103,
1155-68 (2000), Mol Cell Biol 23, 3965-73 (2003)). However, when
Rec8 was expressed ectopically during mitosis, Rec8 was localized
largely at centromeres but disappeared at anaphase, with sister
chromatids segregating to opposite sides (FIGS. 1c and d).
Moreover, the ectopic expression of non-cleavable Rec8 during
mitosis (note that Rec8 is cleaved by separase Cut1 during meiosis
(Embo J 22, 5643-53 (2003))) resulted in an inability to separate
sister chromatids (see FIG. 2). Thus, in contrast to the situation
during meiosis I, centromeric Rec8 is cleaved by separase during
mitosis, and results in separation of sister chromatids. The
present inventor thus postulated a meiosis I specific centromeric
protector of Rec8 from these observations. To identify this factor,
the present inventor searched for a gene that generates toxicity
during mitotic growth only when co-expressed with Rec8. This
screening identified a novel gene, sgo1+ (ORF: SPBP35G2.03C). The
hindrance of growth by Sgo1 was significantly dependent on Rec8, as
Sgo1 had little effect on growth when co-expressed with Rad21 (FIG.
1a). Co-expression of rec8+ and sgo1+ resulted in high frequency of
the blocked nuclear division, as centromere-associated green
fluorescent protein markers (cen2-GFP) segregated to the same side
of a septated cell highly frequently (see Figs. b and c). To test
the possibility that Sgo1 protects Rec8 from degradation at
anaphase, the localization of Rec8 was examined in associated with
Sgo1 expression, Rec8 tagged with GFP at its carboxyl terminus was
expressed under the control of a constitutive adh1 promoter and
induced Sgo1 by using a thiamine-repressible nmt1 promoter.
Consequently it was found that the Rec8-GFP signal persisted
through anaphase only when Sgo1 was co-expressed (FIG. 1d). As Sgo1
is expressed exclusively in meiosis (DNA micro array data (Nat
Genet. 32, 143-7 (2002)), see below), it was found from the
above-mentioned results, that Sgo1 is a protector of Rec8 during
meiosis.
(Sgo1 Protects Centromeric Cohesion at Meiosis I)
[0054] To examine whether Sgo1 is actually required for the
protection of Rec8 during meiosis, the entire ORF encoding sgo1+
was deleted, and the phenotype was examined. Sgo1.DELTA. cells are
viable and showed normal vegetative growth, consistent with the
concept that sgo1+ is a meiosis-specific gene. To examine the
meiotic chromosome segregation of sgo1.DELTA. cells,
centromere-linked sequences were marked with GFP (cen2-GFP) on only
one of the two homologues in a zygote, and the segregation of the
GFP dots were monitored during meiosis I. It was revealed that
meiosis I emerged normally in sgo1.DELTA. cells, as sister
chromatid pairs generally moved together to the same side of each
zygote. Therefore, monopolar attachment was intact (FIG. 3a).
Moreover, by marking cen2-GFP on both chromosomes, it was
determined that accurate segregation was undergone with homologues
at meiosis I (data not shown). However, sister chromatid pairs
failed to segregate properly at meiosis II, non-segregation was
caused in 50% of the cells or less (FIG. 3a). This value is
consistent with random chromosome segregation at meiosis II.
[0055] To examine centromeric cohesion, cen2-GFP marked on both
homologues was monitored in zygotes arrested prior to meiosis II
via a mes1.DELTA. mutation. Supporting the above results,
sgo1.DELTA. cells frequently showed precocious division of
centromeres as split cen2-GFP signals prevailed in the dyad nuclei
(FIG. 3b). Finally, it was examined whether protection of Rec8 at
centromeres is dependent on Sgo1 by monitoring Rec8-GFP at late
anaphase I and prometaphase II. While it is significant that Rec8
signals were centromeric in wild-type cells, the Rec8 signals had
largely disappeared from the centromeres at these stages in
sgo1.DELTA. cells (FIG. 3c). Although all phenotypes of sgo1.DELTA.
cells are reminiscent of heterochromatin-deficient
Schizosaccharomyces pombe, in which Rec8 localization to the
pericentromeric regions is decreased and centromeric cohesion is
lost during meiosis I, leading to random division at meiosis II
(Science 300, 1152-5 (2003)). Chromatin binding by Rec8 was
examined in cells arrested prior to meiosis I by using a chromatin
immunoprecipitation (ChIP) assay. In marked contrast to
heterochromatin-deficient cells, Rec8 localization was intact in
sgo1.DELTA. cells at the pericentromeric regions as well as all
other regions tested. These results suggest that the loss of
centromeric Rec8 after meiosis I is caused not by an initial defect
in Rec8 localization to centromeres but rather by a defect in the
preservation of centromeric Rec8 during meiosis I. The above
results indicated that the Cut1 separase becomes active at the
onset of anaphase I and cleaves most chromosomal Rec8, leaving only
centromeric Rec8 intact (Embo J 22, 5643-53 (2003)). These results
indicated that Sgo1 plays an essential role in protecting
centromeric cohesion throughout meiosis I by protecting cohesin
Rec8 from separase cleavage.
(Sgo1 Localizes at Centromeres During Meiosis I)
[0056] To detect the Sgo1 protein, Sgo1-specific antibodies were
produced, and the results of Western blotting indicated that Sgo1
is expressed only around at meiosis I (FIG. 4a). The results of
immunofluorescence microscopy on cells at various stages of meiosis
revealed that Sgo1 appears at late prophase of meiosis I and is
fully localized as several punctuate dots by the point of metaphase
I (FIG. 4b). These dots were co-localized with the Mis6 kinetochore
protein (Cell 90, 131-143 (1997)), and indicated that Sgo1 is a
centromere-associating protein (FIG. 4c). At the onset of anaphase
I, Sgo1 signals decrease dramatically. It was found that Sgo1
remains undegraded at centromeres in APC-depleted cells arrested at
metaphase I but undergoes normal degradation in separase-defective
cells (FIG. 5), and indicated that Sgo1 degradation at anaphase I
is regulated more directly by the APC rather than through separase.
Although residual Sgo1 signals were detectable at the centromeres
in early anaphase I, they disappeared completely by the end of
anaphase I (FIG. 4b). This indicates that a substantial amount of
Sgo1 is required at the onset of anaphase I when separase is fully
activated. However, it is considered that the amounts of Sgo1
required are smaller and smaller as anaphase I progressed. This
idea is tenable when the separase, activity is quickly
down-regulated or when the access to chromosomes is prevented
during anaphase I. Sgo1 never reappears during meiosis II (FIG.
4b), and which is consistent with the idea that Sgo1 is required
for the protection of Red8 only during meiosis I.
[0057] The present inventor has already reported that Rec8
localization at pericentromeric regions is especially important for
the persistence of centromeric cohesion throughout meiosis I
(Science 300, 1152-5 (2003)). If Sgo1 is a centromeric protector of
Rec8, then it might be expected to localize there as well. To test
this possibility, Rec8 localization was delineated more precisely
by using the ChIP assay. Sgo1 actually associated with
pericentrmeric heterochromatin regions rather than with central
core regions along the centromere sequences (FIG. 4d). As the
results of immunoprecipitation experiments indicated that Sgo1
interacts with Rec8 complexes in vivo (FIG. 4f), the protection was
carried out through close interaction. Concurrently, these results
indicate that Sgo1 resides at pericentromeric regions and acts to
protect centromeric Rec8 from the cleavage of separase at anaphase
I (FIG. 4d). It was found that the localization of Rec8 does not
depend on Sgo1, and vice versa (FIG. 3d, figure not shown).
Actually, the Rec8 and the Sgo1 are in fact independently generated
at pericentromeric regions, as for the localization, the Rec8 and
the Sgo1 depend on heterochromatin and Bub1 kinase respectively
(FIG. 4e). In contrast, Rec8 and Sgo1 are localized at centromeres
in swi6.DELTA. (heterochromatin deficient) and bub1.DELTA. cells
respectively (FIG. 4e). Thus by localizing independently, it can be
ensured that Rec8 is protected only at centromeres not along the
chromosomal arm regions.
[0058] Further, it is indicated that shugoshin shields Rec8
physically from the action of separase and counteracts the effects.
On this point, even when the strong expression of Sgo1 dose not
express Rec8, the mitotic growth was moderately disturbed (figure
not shown); and even when the temperature is tolerated for cut1
allele, it was found that cut1 mutant was killed by moderate
expression of Sgo1 (FIG. 6).
(Sgo2 is a Mitotic Sgo1 Paralogue in Fission Yeast)
[0059] By a conventional BLAST search of genome databases, the
present inventor identified Sgo1-like proteins from Saccharomyces
cerevisiae and Neurospora crassa, and indicated that Sgo1 is a
conserved protein (see below). In the same search, a
Schizosaccharomyces pombe Sgo1 paralogue which the present inventor
named Sgo2, was also identified (ORF: SPAC15A10.15). The sgo2+ gene
was disrupted, and it was identified that sgo2.DELTA. cells are
viable but show sensitivity to the spindle destabilizing drug
thiabendazole (TBZ) (FIG. 7a). As sgo1.DELTA. cells never show such
a defect, this phenotype is remarkable. To investigate its cellular
distribution, the endogenous sgo2+ gene was tagged with GFP. In
proliferating cells, Sgo2-GFP was observed as two or three dots in
the nucleus (FIG. 7d). However, Sgo2-GFP co-localized with the
centromere protein Mis6 at metaphase and disappeared during
anaphase (FIGS. 7c and d). The results of ChIP assays showed that
Sgo2 chromatin association is detectable only on synchronous
populations of mitotic cells, and that chromatin association is
localized to the pericentromeric regions (FIG. 7e). By enhancing
this localization, sgo2 deletion confers a dramatic defect to
chromosome segregation when the heterochromatin-deficient
swi6.DELTA. mutation was bound thereto, however which by itself
impairs centromeric function slightly (Science 269, 1429-31 (1995))
(FIG. 7b). These results indicate that Sgo2 cooperates with
centromeric heterochromatin factors to ensure chromosome
segregation at mitosis. Moreover, it was found that sgo2.DELTA.
cells have a modest increase (up to 15%) in non-segregation of
homologues at meiosis I, and indicated that Sgo2 is also important
for promoting proper meiosis I. However, the role of Sgo2 does not
overlap with that of Sgo1, as sgo1.DELTA. neither causes an
apparent defect at meiosis I (FIG. 3a) nor enhances a defect of
sgo2 in meiosis.
(Shugoshin Localization Controlled by Bub1)
[0060] As centromeric Rec8 cannot be detected after meiosis I in
fission yeast bub1 mutants, a conserved centromere-associated
kinase Bub1 is considered to function in protecting Rec8 during
meiosis, (Nat Cell Biol 3, 522-6 (2001)) (FIG. 3c). Although bub1
mutation has pleiotropic effects in meiotic chromosome segregation,
it is considered that Sgo1 function can be targeted by Bub1
activity. To elucidate this problem, Sgo1-GFP signals were examined
in bub1.DELTA. cells undergoing meiosis. Obviously, Bub1.DELTA.
cells were almost completely devoid of accurate centromeric
Sgo1-GFP signals, instead showed a diffuse fluorescence in the
nucleus (FIG. 4e). Similar results were obtained by using the
bub1-K762R point mutation that abolishes the kinase activity (Embo
J 22, 1075-87 (2003)). Although substantial levels of Sgo1 protein
were detected in meiotic bub1.DELTA. cells by Western blot analysis
(figure not shown), Bub1 dose not influence protein stability of
Sgo1. Thus, the kinase activity of Bub1 is required for
incorporating Sgo1 to centromeres, and the observed defects in
centromeric protection in bub1.DELTA. cells can be explained by
impaired localization of Sgo1.
[0061] In parallel experiments, it was identified that mitotic Sgo2
localization at centromeres was similarly disturbed in bub1 mutants
(FIG. 7c). It has been indicated that loss of Bub1 function causes
centromeric function to be weakened (J Cell Biol 143, 1775-87
(1998)). In this regard, the bub1-K762R mutation shows co-lethality
with swi6.DELTA., a mutation that also slightly impairs centromeric
function via its role in pericentromeric heterochromatin formation.
It was found that sgo2.DELTA. similarly shows co-lethality with
swi6.DELTA. (FIG. 7b), and exhibits severe miss-segregation of
chromosomes at mitosis (figure not shown). As the sgo2.DELTA.
bub1.DELTA. double mutant showed no cumulative defects at all in
growth or TBZ sensitivity (FIG. 7a), Sgo2 and Bub1 tandem function
was confirmed to ensure chromosome segregation in mitosis by these
genetic analyses. Taken all together, the above results revealed
that the incorporation of Sgo1 and Sgo2 to centromeres is a crucial
function of Bub1 kinase in meiosis and mitosis, respectively.
(Characteristics of a Budding Yeast Sgo1 Homologue)
[0062] The present inventor identified a single Sgo1 homologue,
ScSgo1 in budding yeast (ORF: YOR073W), which has so far not been
analyzed. The cellular localization of ScSgo1 was examined by
tagging endogenous ScSGO1 with GFP. ScSgo1-GFP was detected mainly
as a single dot in proliferating cells, but only in a limited
subset of the population (FIG. 8a). Scsgo1-GFP was not detected
during the G1/S period (i.e. in cells with no bud or a small bud)
but appeared as a dot in G2/M (cells with a large bud and a single
nucleus) and disappeared at anaphase (cells with a large bud and a
stretched nucleus) (FIG. 8a). The dot is co-localized with Ndc10
kinetochore protein (FIG. 8b). During meiosis, ScSgo1-GFP was
detected at the kinetochore only at metaphase I, but never during
anaphase I or meiosis II (FIG. 8c). Thus, the pattern of ScSgo1
localization closely resembles that of SpSgo2 in mitosis and SpSgo1
in meiosis.
[0063] The ScSGO1 gene was disrupted to examine the function of
ScSgo1. Although the Scsgo1.DELTA. cells were viable, they grew
slowly and showed sensitivity to the spindle destabilizing drug
benomyl (FIG. 8d), and indicated that centromeric function might be
impaired. And then the chromosome loss rates in Scsgo1.DELTA. cells
were compared with those in wild-type cells by a colony sectoring
assay. Whereas 40% of the Scsgo1.DELTA. colonies contained red
sectors (which indicate chromosome loss), less than 2% wild-type
colonies contained such sectors (FIG. 8e). It was concluded that
ScSgo1 plays a crucial role at centromeres to ensure mitotic
chromosome segregation. At the onset of meiosis, Scsgo1.DELTA.
cells showed significant defects that many cells are arrested with
a single nucleus in the meiotic condition. However, among the
leaked tetranucleate products of meiosis, the distribution pattern
of cenV-GFP was consistent with proper segregation at meiosis I
with the exception of random segregation at meiosis II (FIG. 8f).
It was also found that tagging chromosomal ScSGO1 with 13Myc at its
carboxyl terminus, which by itself causes no detectable defects in
mitotic growth or meiosis I, resulted in impaired segregation at
meiosis II (34% non-segregation indicates 68% random
segregation)(FIG. 8g). Moreover, the ScSGO1-Myc cells showed
frequent separation of sister centromeres at late meiotic anaphase
I (FIG. 8h), indicated that centromeric cohesion was not properly
protected. Concurrently, these results support the idea that ScSgo1
plays a crucial role in protecting centromeric cohesion throughout
meiosis I, and meiosis II was ensured thereby as is the case with
fission yeast Sgo1.
(Conservation of Shugoshin Among Eukaryotes)
[0064] BLAST searches identified only three Sgo1-like proteins,
which were all in fungi: Schizosaccharomyces pombe Sgo2,
Saccharomyces cerevisiae ScSgo1, and Neurospora crassa B23G1.060.
As the two conserved regions were found in these proteins, the
related proteins are searched under conditions of two block
sequences by the BLOCK MAKER and MAST programs (Nucleic Acids Res
26, 309-12 (1998), Bioinformatics 14, 48-54 (1998)). This approach
extracted several candidate proteins from various eukaryotes
including fly, worm, plant, mouse and human (see SEQ ID Nos: 21-37;
drosophila Dm, Ce, Arabidopsis At, mouse Mm and human Hs,
respectively, in FIG. 9). Especially, this list includes Drosophila
ME1-S332, which is previously characterized as a protein essential
for preserving centromeric cohesion in meiosis (Cell 83, 247-256
(1995)), although the similarity score is marginal (E-value=10).
All other proteins in the list show a short stretch of similarity
in the carboxyl terminal basic regions, while the primary sequences
in the first block are not conserved except that they all contain a
putative coiled-coil. The space and sequences between these two
blocks diverge among the proteins. As these blocks were previously
identified to be important for ME1-S332 function (Genes Dev. 12,
3843-3856 (1998)), the importance of the conserved regions in Sgo1
was investigated. Several amino acids were changed individually to
alanines in these similarity blocks and the function of the mutant
proteins in vivo was examined (FIG. 10). It was found that three
conserved amino acids known to be important for ME1-S332 function
were also required for Sgo1 function (13N, 34V and 368S in
ME1-S332; 29N, 501 and 294S in Sgo1) (marked as arrowheads in FIG.
9). Further, other conserved amino acids in the second block (293P,
296R, 298K, 299L and 300R in Sgo1) were also all required for Sgo1
function (asterisks in FIG. 9), and non-conserved residue 297T
could be changed to alanine without impairing function (circle in
FIG. 9). These results indicated that the marginal structural
similarity observed among Schizosaccharomyces pombe Sgo1 and other
proteins in various eukaryotes is important. Plants and mammals
carry two shugoshin-like proteins, suggesting the possibility that
the function of shugoshin diverges to complete mitosis and meiosis
as in fission yeast.
(Proteins Encoding Human Shugoshin Homologous Gene are Specifically
Localized at Centromeres in Mitosis)
[0065] The present inventor previously identified two putative
human Sgo proteins, Sgo1 and Sgo2 in the database, although their
overall sequence homology to known Sgo proteins in any species
other than human is marginal (FIG. 11a). To examine whether these
proteins identified in the database are actually human Sgo
homologs, the present inventor examined the localization of the
proteins. For this end, the present inventor cultured rabbit
polyclonal antibodies against recombinant proteins that were
produced in bacteria. The obtained Sgo1 antibodies detected an up
to 70 kD band (predicted molecular weight is 60 kD) in the HeLa
cell extracts, and the signal was significantly reduced when cells
were treated with siRNA that targets Sgo1 mRNA (FIG. 11b).
Similarly, Sgo2 antibodies detected an up to 120 kD band (predicted
molecular weight is 145 kD), the signal was reduced in extracts
obtained from cells treated with Sgo2 siRNA (FIG. 11b). These data
indicate that both Sgo1 and Sgo2 are expressed at least in
proliferating HeLa cells. Next, for the purpose of analyzing
proteins (SEQ ID NOs: 18 and 20, respectively hSgo1 and hSgo2)
encoding human shugoshin homologous gene (SEQ ID NOs: 17 and 19)
that was presumed to be human Sgo homologues, part of hSgo1 and
hSgo2 was expressed in E. coli, and antibodies against hSgo1 and
hSgo2 were produced by injecting the protein into rabbit, HeLa
cells were stained with the antibodies and concurrently with tublin
antibodies and DAPI, and co-stained with spindle and chromosome DNA
respectively, and the expression of hSgo1 and hSgo2 proteins that
were both endogeneous in proliferating cells was examined. The
results are shown in FIG. 12. As shown in FIG. 12, both signals of
hsgo1 and hSgo2 were also observed as dots on chromosomes from
prometaphase to metaphase. As a result of the immunostaining, it
was identified that both proteins, hsgo1 and hSgo2 are specifically
localized at centromeres at mitotic phase. Further, HeLa cells at
prometaphase and metaphase were stained with antibodies against
hsgo1 or hSgo2; concurrently co-stained with antibodies against
centromere protein CENP-A, and DAPI; and examined the expression of
hsgo1 and hSgo2 proteins. The results are shown in FIG. 13. As
shown in FIG. 13, both signals of hSgo1 and hSgo2 were observed at
sites close to CENP-A dots on chromosomes. As a result of the
above, it was revealed that both hsgo1 and hSgo2 are centromere
proteins. Further, to examine this possibility, Aurora B, which is
a passenger protein of chromosome known to be localized within
kinetochore from prophase to metaphase, was stained. The sites of
Sgo1 and Aurora B were practically the same at prometaphase and
metaphase, whereas Sgo2 was placed just outside Aurora B (see FIG.
13). As a result of the above, it was revealed that both hsgo1 and
hSgo2 are placed within kinetochores from prometaphase to
metaphase. Representative views of sister kinetochore are magnified
on the right. Scale bar is 10 .mu.m.
(Proteins Encoding Human Shugoshin Homologous Gene are Specifically
Localized at Centromeres in Mitosis and Play an Important Role to
Progress Chromosome Segregation)
[0066] RNAi experiments targeting hsgo1 and hSgo2 were performed
respectively. The results are shown in FIG. 14. As a result, the
expressions in any proteins were significantly suppressed 48 hours
later, the cells arrested in mitosis (total, in figure) were
accumulated as indicated in FIG. 14. As described above, it was
strongly suggested that any protein localized at centromeres in
mitosis plays an important role for progressing chromosome
segregation. As the accumulation was dissolved by suppressing a
spindle checkpoint factor BubR1 by RNAi, it was suggested that
hsgo1 and hSgo2 are directly or indirectly function during the
process where spindle properly takes the kinetochore at centromeres
as described below.
[0067] Further, the cells for which RNAi experiments targeting
hsgo1 was performed by using HeLa cells were mounted on a slide
glass and stained with Giemsa. The results are shown in FIG. 15. It
was revealed that sister chromatid at prophase strongly adhered at
centromere site in control cells where RNAi was not performed;
while in cells suppressing hsgo1 expression, where RNAi was
performed, the adhesion was weak at centromere site, and easily
detached. Consequently, it was demonstrated that hsgo1 has an
important role to maintain the strong cohesion at centromere site
in mitosis in proliferating cells. Mitotic cells where Sgo1 protein
knockdown was performed by RNAi experiments were collected, and the
chromosomes were spread to observe chromosome structure directly.
In control cells, sister chromatids were resolved along the arm
regions but showed the primary constriction at centromeres (FIG.
16a i). Amazingly, in Sgo1-depleted cells, sister chromatids were
often separated along the whole chromosome length (FIG. 16a iii).
In samples where sister chromatids stayed densely close, although
sister chromatids did not indicate the primary constriction (FIG.
16a iv), this suggests that centromeric cohesion was lost
selectively. Nocodazole treatment activates the spindle checkpoint;
thereby the cell cycle is arrested at prometaphase. Such prolonged
arrest in M phase causes the complete separation of the
connectivity from the chromosomal arm regions. For this reason,
sister chromatids are only connected at centromeres, and form
`Xshaped` chromosome (FIG. 16b, control). As expected,
nocodazole-treatment caused the complete separation of sister
chromatids along the chromosome length in Sgo1 RNAi cells (up to
97%) (FIGS. 16c and d). Consequently, it was demonstrated that
hSgo1 plays an important role to maintain the strong cohesion at
chromosomal centromere site in mitosis in proliferating cells.
[0068] RNAi experiments targeting Bub1 were performed respectively.
The results are shown in FIG. 17. Consequently, the localization of
either protein of the hsgo1 and hSgo2 to centromere was
disappeared. This result means that the conclusion, "localization
of shugoshin to centromere depends on Bub1 kinase", which was found
in yeast by the present inventor, is also conserved in higher
organisms.
[0069] Next, clone where cDNA of mouse shugoshin homologous genes
(SEQ ID NOs: 21 and 23) was fused with GFP gene was produced by
using retroviral vector and expressed in human HeLa cells. The
results are shown in FIG. 18. Consequently, it was revealed that
any of the GFP fusion proteins are also co-localized with human
kinetochore protein Bub1 in mitosis.
[0070] The analysis of the above hsgo1 and hSgo2 and the analysis
results obtained with the use of mouse shugoshin homologous genes
were strongly suggested that shugoshin-like protein in animal
cells, which were predicted from the sequence, also have functional
conservation with yeast shugoshin.
INDUSTRIAL APPLICABILITY
[0071] Shugoshin of the present invention that is a regulatory
factor of chromosome segregation widely conserved in eukaryotic
cells, can be advantageously used for studies on the induction
mechanism of cancer in somatic division, the chromosome segregation
diseases such as infertility or Down's syndrome in meiotic
division, and the like besides on the elucidation of mechanism in
chromosome segregation.
Sequence CWU 1
1
451960DNAyeast 1atgaactttc aatttataaa ttcaaatata aacaatgaag
ataaattgcc gatggagtcg 60ttgaaaaaga aatttttaaa acaaaatcgt gaaattataa
aaataaatac tcagctttct 120ataaaaatta gagaatctga aaacgaaatt
caagatttga tacaagaaaa tttcactttg 180aaaagttatt tggttaaact
tgaagctcga tttcgcaatc aatctcaaac tgaggacttg 240ttaaaaaact
tctttcctga gatacaaacc attcacaaaa agatttcaca agtgcaaagt
300ttactgaaga ttatagagaa aaagtgttca tcagatttcc tcgaagcgaa
tgtaaaaagt 360caatttacaa cctgtgaaaa taaagattcg aaagaagatt
atcagatttt gcataataaa 420cgcttggagt atgtatcatt taatgatgaa
cttaaaagtc tcgaaacagg gcaaccattg 480tattgttttc aagatttcca
aaaaaaagtc catggtcctc cggctctatc tgaaaaacct 540ggaaaatgta
tattaaaaga taaaaccaat gcccacgtaa acaaaatacc acaagatgag
600gtgaattact cattgccgca aaaaaatatc accatctttt caaaggaatt
aaaagaaaac 660gaatttgaat ccatcaacga gggcgaaact gaagaagaaa
aggctaaaac atcaaatgtt 720tgtgtttgta ttccttgtaa aagtgctgaa
cagataactg accttaaagg acaagcaacc 780ggagacagct ccccatgtga
ttttgaagaa tctcaaccaa ggattaatgg acgtgaaaaa 840ctaagacgat
cagtcaaagt gataaactat gcaataccca gtttgcgaac taaactacga
900cgagactttg acttaccatc tgatagaaaa cgcaaacgac atcccagagg
caaagcataa 9602319PRTyeast 2Met Asn Phe Gln Phe Ile Asn Ser Asn Ile
Asn Asn Glu Asp Lys Leu1 5 10 15Pro Met Glu Ser Leu Lys Lys Lys Phe
Leu Lys Gln Asn Arg Glu Ile 20 25 30Ile Lys Ile Asn Thr Gln Leu Ser
Ile Lys Ile Arg Glu Ser Glu Asn 35 40 45Glu Ile Gln Asp Leu Ile Gln
Glu Asn Phe Thr Leu Lys Ser Tyr Leu 50 55 60Val Lys Leu Glu Ala Arg
Phe Arg Asn Gln Ser Gln Thr Glu Asp Leu65 70 75 80Leu Lys Asn Phe
Phe Pro Glu Ile Gln Thr Ile His Lys Lys Ile Ser 85 90 95Gln Val Gln
Ser Leu Leu Lys Ile Ile Glu Lys Lys Cys Ser Ser Asp 100 105 110Phe
Leu Glu Ala Asn Val Lys Ser Gln Phe Thr Thr Cys Glu Asn Lys 115 120
125Asp Ser Lys Glu Asp Tyr Gln Ile Leu His Asn Lys Arg Leu Glu Tyr
130 135 140Val Ser Phe Asn Asp Glu Leu Lys Ser Leu Glu Thr Gly Gln
Pro Leu145 150 155 160Tyr Cys Phe Gln Asp Phe Gln Lys Lys Val His
Gly Pro Pro Ala Leu 165 170 175Ser Glu Lys Pro Gly Lys Cys Ile Leu
Lys Asp Lys Thr Asn Ala His 180 185 190Val Asn Lys Ile Pro Gln Asp
Glu Val Asn Tyr Ser Leu Pro Gln Lys 195 200 205Asn Ile Thr Ile Phe
Ser Lys Glu Leu Lys Glu Asn Glu Phe Glu Ser 210 215 220Ile Asn Glu
Gly Glu Thr Glu Glu Glu Lys Ala Lys Thr Ser Asn Val225 230 235
240Cys Val Cys Ile Pro Cys Lys Ser Ala Glu Gln Ile Thr Asp Leu Lys
245 250 255Gly Gln Ala Thr Gly Asp Ser Ser Pro Cys Asp Phe Glu Glu
Ser Gln 260 265 270Pro Arg Ile Asn Gly Arg Glu Lys Leu Arg Arg Ser
Val Lys Val Ile 275 280 285Asn Tyr Ala Ile Pro Ser Leu Arg Thr Lys
Leu Arg Arg Asp Phe Asp 290 295 300Leu Pro Ser Asp Arg Lys Arg Lys
Arg His Pro Arg Gly Lys Ala305 310 31531944DNAyeast 3atgtcgaaag
catctctttc cccgaacgta gaagacttga aaaaaaagca aattcgacag 60tataaggaaa
ttatacgaat aagcaaggca caatcaatta gaattaaaga attgcagtta
120gaaaatgaac ggttgctttc ggaaaatatc gatttgagga ctacagcgat
aaacttggaa 180gagcaactcg aaaccgtgca aaacgaaaac gaagaaaaca
aaacaaagtt agctgcatta 240cttaatcgat ttcatgaaga aacagataat
tttttatcaa aattaagtct ttgtcagcaa 300gaaatacaag acaccttcaa
accagtggag gctaacttag cttacgatgt cgatacggat 360tctgaagacc
ttgacgagga atccgtcgtg aaagataccg aagaaataat tgagcaagct
420cagcatgatg tttccttacg aaatttaagt ggaatagagg atgaaaatat
aattgatgac 480ggagaaactg ctataaatga acaaaaaaaa agagaagcta
atgttttttc cgacacgcaa 540tcagcacctc agctaaaatc cggcaaagcc
ctcccagctg attttgaaaa tccttacaat 600ctatccaatt cgaaacctgt
aaataataat aatgaagata gagttgaagc ggttacttct 660gaaaataaat
ctatcgattc tgctcctcag gaaaaaaatc atgaatacga aatcgttagt
720ccaaaatcat tatccaacaa aattaataat caagcagctg cacaaagaag
aaccgaagaa 780gataatgcaa atggagttgc tcaagaagaa aatgagggtt
cacaagaagc tcattttcat 840agcagaatac aatctgatac agtaatacaa
agtacaccca ctaaacggaa atgggacgtt 900gacattcaaa ataaacaaat
taatctggct tctgcagcta ccaatgttac cggttatgta 960tcggagaccg
atagtcgccc caatcgcgca aactctttgg attctgctgt ccttcttgtg
1020caatcttcaa ataaaagtaa ccgaaatggg catcatattt cagatcctaa
tttaaatagc 1080tccatatcgt tgaagtttgc gcctgaagat actgcgcata
attcattaac ttcacaagag 1140aatgttgggc ctcaggttac gacgacttct
ctgtcaaata tgactgttgc tgaatctcct 1200cgtacagaca ctccaaggga
aataaacggg ttagtagact cttctgtcac taatgggaac 1260gaaaaatttt
ctgtagaaat aatgaatgac tctaacaaaa ttggactgaa tcctaaatct
1320tttaccgacg aagagcggga aattttaaca ctttttcgaa atcctcccat
gagactgtca 1380agtgaacctc catcttcaaa tggattttca atagcccatc
ccaataattc tccgttacgt 1440ccgccatcgc tacaaggaat attgaatgct
gaagatcgac cttacgaaat tgagccgtca 1500cgtagctcct ttgctaccaa
cgatacgggc tcctataata atttggaact tctgtcatct 1560gtaacgaatt
tgaaatcccc taatgagaac gatcgtgtga cgaaaactca gtcgcgaaga
1620gaaacaaaag tgaaaaggcg aagaaaagct cggattcaag aaacttctga
agaaagtaca 1680gtagtcaatg agccaaatga aaaacctgat ggaaggagcc
gaagggaacg gaaaaaggtt 1740aattacgctt tgcctggatt aaggacgaaa
ttaagacgga atttcgattt accttcagat 1800catgtaaaag ctaaaaaaac
gagacgtgct cctaagaact ctgagaatga ttcagctacc 1860aaaacagaaa
ccgcaaacat tacttctgaa gcacccacta cttcagaagt aacccttgaa
1920aactccgaaa cccttaattt gtaa 19444647PRTyeast 4Met Ser Lys Ala
Ser Leu Ser Pro Asn Val Glu Asp Leu Lys Lys Lys1 5 10 15Gln Ile Arg
Gln Tyr Lys Glu Ile Ile Arg Ile Ser Lys Ala Gln Ser 20 25 30Ile Arg
Ile Lys Glu Leu Gln Leu Glu Asn Glu Arg Leu Leu Ser Glu 35 40 45Asn
Ile Asp Leu Arg Thr Thr Ala Ile Asn Leu Glu Glu Gln Leu Glu 50 55
60Thr Val Gln Asn Glu Asn Glu Glu Asn Lys Thr Lys Leu Ala Ala Leu65
70 75 80Leu Asn Arg Phe His Glu Glu Thr Asp Asn Phe Leu Ser Lys Leu
Ser 85 90 95Leu Cys Gln Gln Glu Ile Gln Asp Thr Phe Lys Pro Val Glu
Ala Asn 100 105 110Leu Ala Tyr Asp Val Asp Thr Asp Ser Glu Asp Leu
Asp Glu Glu Ser 115 120 125Val Val Lys Asp Thr Glu Glu Ile Ile Glu
Gln Ala Gln His Asp Val 130 135 140Ser Leu Arg Asn Leu Ser Gly Ile
Glu Asp Glu Asn Ile Ile Asp Asp145 150 155 160Gly Glu Thr Ala Ile
Asn Glu Gln Lys Lys Arg Glu Ala Asn Val Phe 165 170 175Ser Asp Thr
Gln Ser Ala Pro Gln Leu Lys Ser Gly Lys Ala Leu Pro 180 185 190Ala
Asp Phe Glu Asn Pro Tyr Asn Leu Ser Asn Ser Lys Pro Val Asn 195 200
205Asn Asn Asn Glu Asp Arg Val Glu Ala Val Thr Ser Glu Asn Lys Ser
210 215 220Ile Asp Ser Ala Pro Gln Glu Lys Asn His Glu Tyr Glu Ile
Val Ser225 230 235 240Pro Lys Ser Leu Ser Asn Lys Ile Asn Asn Gln
Ala Ala Ala Gln Arg 245 250 255Arg Thr Glu Glu Asp Asn Ala Asn Gly
Val Ala Gln Glu Glu Asn Glu 260 265 270Gly Ser Gln Glu Ala His Phe
His Ser Arg Ile Gln Ser Asp Thr Val 275 280 285Ile Gln Ser Thr Pro
Thr Lys Arg Lys Trp Asp Val Asp Ile Gln Asn 290 295 300Lys Gln Ile
Asn Leu Ala Ser Ala Ala Thr Asn Val Thr Gly Tyr Val305 310 315
320Ser Glu Thr Asp Ser Arg Pro Asn Arg Ala Asn Ser Leu Asp Ser Ala
325 330 335Val Leu Leu Val Gln Ser Ser Asn Lys Ser Asn Arg Asn Gly
His His 340 345 350Ile Ser Asp Pro Asn Leu Asn Ser Ser Ile Ser Leu
Lys Phe Ala Pro 355 360 365Glu Asp Thr Ala His Asn Ser Leu Thr Ser
Gln Glu Asn Val Gly Pro 370 375 380Gln Val Thr Thr Thr Ser Leu Ser
Asn Met Thr Val Ala Glu Ser Pro385 390 395 400Arg Thr Asp Thr Pro
Arg Glu Ile Asn Gly Leu Val Asp Ser Ser Val 405 410 415Thr Asn Gly
Asn Glu Lys Phe Ser Val Glu Ile Met Asn Asp Ser Asn 420 425 430Lys
Ile Gly Leu Asn Pro Lys Ser Phe Thr Asp Glu Glu Arg Glu Ile 435 440
445Leu Thr Leu Phe Arg Asn Pro Pro Met Arg Leu Ser Ser Glu Pro Pro
450 455 460Ser Ser Asn Gly Phe Ser Ile Ala His Pro Asn Asn Ser Pro
Leu Arg465 470 475 480Pro Pro Ser Leu Gln Gly Ile Leu Asn Ala Glu
Asp Arg Pro Tyr Glu 485 490 495Ile Glu Pro Ser Arg Ser Ser Phe Ala
Thr Asn Asp Thr Gly Ser Tyr 500 505 510Asn Asn Leu Glu Leu Leu Ser
Ser Val Thr Asn Leu Lys Ser Pro Asn 515 520 525Glu Asn Asp Arg Val
Thr Lys Thr Gln Ser Arg Arg Glu Thr Lys Val 530 535 540Lys Arg Arg
Arg Lys Ala Arg Ile Gln Glu Thr Ser Glu Glu Ser Thr545 550 555
560Val Val Asn Glu Pro Asn Glu Lys Pro Asp Gly Arg Ser Arg Arg Glu
565 570 575Arg Lys Lys Val Asn Tyr Ala Leu Pro Gly Leu Arg Thr Lys
Leu Arg 580 585 590Arg Asn Phe Asp Leu Pro Ser Asp His Val Lys Ala
Lys Lys Thr Arg 595 600 605Arg Ala Pro Lys Asn Ser Glu Asn Asp Ser
Ala Thr Lys Thr Glu Thr 610 615 620Ala Asn Ile Thr Ser Glu Ala Pro
Thr Thr Ser Glu Val Thr Leu Glu625 630 635 640Asn Ser Glu Thr Leu
Asn Leu 64551773DNAyeast 5atgccgaaga gaaaaattgc tcctaacaag
gaaagcagca ggcgtacggt ctcccacgat 60gatttaaccc cacaaataca agaatttcaa
aacctaatgg atctcgaatc gcaaaaagtg 120gaaaacatca gacagtcgta
ttcgaggcaa aactccctgc tggccaagga taactccata 180ttaaaaatta
aagttaatag cttggaaaaa aaaataagcc agctggtaca agaaaacgtg
240actctacgat ctaaaacctc tataagcgaa gctatctaca gggaacggtt
aagtaatcaa 300ctacaagtca ttgaaaacgg tattattcaa agatttgacg
aaatttttta tatgtttgag 360aacgtacgta aaaacgaaaa tttgcccagt
tcgagcttaa gaacaatgtt gaagagaacg 420agttccaggt caagatcatg
ctcattgtca tcacccacat actcaaaaag ttacactagg 480ttatcaaatc
acgagaataa cctgtcgcat gaatcaagtt ttaacaagga cgatggtcca
540gatcttgagc ctaaggctaa aaaaaggaag agttctaggc ggcaatctat
gtttgtatcc 600acgagtttag aacctgaaga cgaaaccggt gaaaacgaac
ccatgatgga aaattcctct 660gtagaggtac cggcagaatc acacgagtct
gcgcaagtgg aggaaacaat agatgcctta 720aaccctgaag aggaaaatag
cgattctgtc agtaatttta ccaattcaat tatagaatac 780tccataccag
aggagaatcc gacagaaccc gagcattcat cttctaaact agaaatattc
840aatgacagta caaatatgct aagtacagtg ccgtcaaatc ctttgccgtt
gcctttacca 900ggcccatccg caactttacc tactaccact agcgatgctt
caacggtcta tccttcatca 960agttcttcta ctaattctca tccaaagacc
aaaattaagc attccatgaa gccgcctagg 1020atagaactga agaaaaaggt
tattgacgaa gtcatgcccg taagtaacat gagcagcaac 1080agcgaaatat
catttacgag aactagaaga actcgtggta aagctgtaga ttacactttg
1140ccttctttaa gagccaaaat gaggaggcct tcagaaaaac ttgtggatgc
tactactgtg 1200attgatatac atgatctaca ggtttccaag agaaatcggg
aaacttcaca taaaaggaaa 1260agtttatccc aagattcaat acccgacgaa
ccgcaattga gagaagtcgt cgtctcaaag 1320gattatggaa ctccaaaagg
gaaaaaaacg gaagatgaaa tacacgagga taccgctcat 1380ctaatgacca
cttccaacaa caacagcaac aacaaaaacg aaaaaaaact aactagcaac
1440aatagcccta aaaaatcgtc gcctttactt gacattacaa ataaatcgga
gaataagaaa 1500aagtcaacaa gaactaaaaa attgttcaaa aatgcaattg
tcaataattt atctgatgaa 1560aattctacta cgcgaccctc caagtcgtca
aagggaacca gtaataataa caacaattac 1620aacaatttcg acaataacaa
ttcaaacatt aataatgtta ataataaatc tgttagcttt 1680agactaaatg
aagatgattt agcagtattt gatttatttg gaaatggtaa ggcagtgaaa
1740catcaaccaa aaacatatcg caccaaaaaa tga 17736590PRTyeast 6Met Pro
Lys Arg Lys Ile Ala Pro Asn Lys Glu Ser Ser Arg Arg Thr1 5 10 15Val
Ser His Asp Asp Leu Thr Pro Gln Ile Gln Glu Phe Gln Asn Leu 20 25
30Met Asp Leu Glu Ser Gln Lys Val Glu Asn Ile Arg Gln Ser Tyr Ser
35 40 45Arg Gln Asn Ser Leu Leu Ala Lys Asp Asn Ser Ile Leu Lys Ile
Lys 50 55 60Val Asn Ser Leu Glu Lys Lys Ile Ser Gln Leu Val Gln Glu
Asn Val65 70 75 80Thr Leu Arg Ser Lys Thr Ser Ile Ser Glu Ala Ile
Tyr Arg Glu Arg 85 90 95Leu Ser Asn Gln Leu Gln Val Ile Glu Asn Gly
Ile Ile Gln Arg Phe 100 105 110Asp Glu Ile Phe Tyr Met Phe Glu Asn
Val Arg Lys Asn Glu Asn Leu 115 120 125Pro Ser Ser Ser Leu Arg Thr
Met Leu Lys Arg Thr Ser Ser Arg Ser 130 135 140Arg Ser Cys Ser Leu
Ser Ser Pro Thr Tyr Ser Lys Ser Tyr Thr Arg145 150 155 160Leu Ser
Asn His Glu Asn Asn Leu Ser His Glu Ser Ser Phe Asn Lys 165 170
175Asp Asp Gly Pro Asp Leu Glu Pro Lys Ala Lys Lys Arg Lys Ser Ser
180 185 190Arg Arg Gln Ser Met Phe Val Ser Thr Ser Leu Glu Pro Glu
Asp Glu 195 200 205Thr Gly Glu Asn Glu Pro Met Met Glu Asn Ser Ser
Val Glu Val Pro 210 215 220Ala Glu Ser His Glu Ser Ala Gln Val Glu
Glu Thr Ile Asp Ala Leu225 230 235 240Asn Pro Glu Glu Glu Asn Ser
Asp Ser Val Ser Asn Phe Thr Asn Ser 245 250 255Ile Ile Glu Tyr Ser
Ile Pro Glu Glu Asn Pro Thr Glu Pro Glu His 260 265 270Ser Ser Ser
Lys Leu Glu Ile Phe Asn Asp Ser Thr Asn Met Leu Ser 275 280 285Thr
Val Pro Ser Asn Pro Leu Pro Leu Pro Leu Pro Gly Pro Ser Ala 290 295
300Thr Leu Pro Thr Thr Thr Ser Asp Ala Ser Thr Val Tyr Pro Ser
Ser305 310 315 320Ser Ser Ser Thr Asn Ser His Pro Lys Thr Lys Ile
Lys His Ser Met 325 330 335Lys Pro Pro Arg Ile Glu Leu Lys Lys Lys
Val Ile Asp Glu Val Met 340 345 350Pro Val Ser Asn Met Ser Ser Asn
Ser Glu Ile Ser Phe Thr Arg Thr 355 360 365Arg Arg Thr Arg Gly Lys
Ala Val Asp Tyr Thr Leu Pro Ser Leu Arg 370 375 380Ala Lys Met Arg
Arg Pro Ser Glu Lys Leu Val Asp Ala Thr Thr Val385 390 395 400Ile
Asp Ile His Asp Leu Gln Val Ser Lys Arg Asn Arg Glu Thr Ser 405 410
415His Lys Arg Lys Ser Leu Ser Gln Asp Ser Ile Pro Asp Glu Pro Gln
420 425 430Leu Arg Glu Val Val Val Ser Lys Asp Tyr Gly Thr Pro Lys
Gly Lys 435 440 445Lys Thr Glu Asp Glu Ile His Glu Asp Thr Ala His
Leu Met Thr Thr 450 455 460Ser Asn Asn Asn Ser Asn Asn Lys Asn Glu
Lys Lys Leu Thr Ser Asn465 470 475 480Asn Ser Pro Lys Lys Ser Ser
Pro Leu Leu Asp Ile Thr Asn Lys Ser 485 490 495Glu Asn Lys Lys Lys
Ser Thr Arg Thr Lys Lys Leu Phe Lys Asn Ala 500 505 510Ile Val Asn
Asn Leu Ser Asp Glu Asn Ser Thr Thr Arg Pro Ser Lys 515 520 525Ser
Ser Lys Gly Thr Ser Asn Asn Asn Asn Asn Tyr Asn Asn Phe Asp 530 535
540Asn Asn Asn Ser Asn Ile Asn Asn Val Asn Asn Lys Ser Val Ser
Phe545 550 555 560Arg Leu Asn Glu Asp Asp Leu Ala Val Phe Asp Leu
Phe Gly Asn Gly 565 570 575Lys Ala Val Lys His Gln Pro Lys Thr Tyr
Arg Thr Lys Lys 580 585 59072325DNANeurospora crassa 7atggcccgcc
tcaacgaaca agccatgtcg tctgtcgcgt tgtcaacaga caatctcgag 60ctcctgcgta
ggaagttcct cagacaaaac agagatattg ctcgagtcaa ttccacacag
120tcactccgta tccgtgggtt ggagaatgaa tgcgctcgtt tgctgtcgga
aaacctcgaa 180ctccgtggtc aggtcttgcg cctcgaaaag gagctccaag
acaacgctgc gcgaagggtg 240gccgatcatg cgctcgaggt caaggccaag
atggagacgc agttggcgga actcagttcg 300ctgctggcaa gcttagggga
gccgccctcg aagcggcgcc tttcagaaga gaggcgatac 360gcgcagcctc
gaccgagcgt tcaccggagc cctcccttac gaagagcacg ccaggaggcc
420gaccaggaac tactggctga gcaggaagga aggctaccgc cgatatacga
gaacaagacg 480tatgcgcgag ccacaatgaa cagtgaagaa atcctggcgc
tgtgcatgca ggcagacgat 540tcgaatgact cgccagatat cggaccgccg
ccagtatcta ggtttgtcga ggatgatatg 600gtcatacctt gttcaccatc
gccaaacaag aacgccgagg ctgaagaaac ggaaactacc 660gagcaagtgg
aagagagccc tagggctctt caagtaccgc cgtcattatc gccgcctaaa
720ctggactacg acaggagacc aaacatgatc ctattcagcc
cacccaaaga atcgagagtg 780gcagaaccct ccaaaatgtt cagtccccct
ccgatggaac caccgaaaca gtccacatcg 840gctgtaccga gtgagacaat
acgagcaggc ctcaagcgaa agttgaacgg cgacaaccaa 900aacgaaccca
acaaggcaac caagcttcaa caaggaaagg agaatggcaa tgagactggg
960atcaagaaag gactctctgc ccgcgacccg cacaagagga aaagcatcaa
agagaccgca 1020acgaaaccga gagccccgct gtcagcaaag agcacgaacg
agcacattgt ctctccgaag 1080aagccggcga agccccacca agtggccgac
gattttaagc cggtgaaggt gcacaaggcg 1140tcaaagggta aagagaaagt
cgacctgccc gctccggaca agaagtcagc agtagaagaa 1200acgcaaggaa
attctacgtc ggcattcacg aaagtcgaga tcctcccgcc ggctctggaa
1260cctactcctg aagttgcaga gattcctgaa accgatattc tgatcacacc
tggaacacca 1320gagcgcgcct ctgaaagcac tgttgtgacc cacgataccc
cgccgccagc ccacatttca 1380tccaatggag agacgtcgcg gcctagcagg
cgtgctagag cggctatcag ctatacagag 1440cccaatctgc gcgacaagat
gcgacgaccg accaaagagc tctttgatgc cgtttctggg 1500gagggcaagt
tcctacacag gccgacatcg caacagcaac agcagcaacg caagggcgac
1560gagtcagcac cgacgtcagt tagcaaggtc aaggtcgagc catcgccggc
ggtggatata 1620agtagtctga ccagcagtgc gctgtttgaa aaagagaagg
agaaggaacc acagccggat 1680gaaggaatat tatctccaaa cggcatcctc
ccaagctcag tagacctggg aaggagaaga 1740cgcgcctcat ccttctctac
tgcagcccct gcaatgacaa ttccttcggt ccaagaacaa 1800tcaactctaa
acctcccagc cgcggacgag accgatgaaa acgccgcggt cgaggctcag
1860attcagaagg agctgagtaa tagtattaca acacggccca ggggtggaaa
ggggaggcaa 1920tcaatgagcc gttccgtacc cacgatccca acagaaaatt
acgagcacga ggacgcacaa 1980ctctcgacga actcagcctc ggtggatctt
tacgactttg ctagttgtgc gtctccggat 2040agcgcagcac cccagctaga
agcgactacc ggcgatgttc ctgttaataa gaaggcaccc 2100aaaggttcaa
gaagagcgtc ctcagctgct tcgaccgaga caacagcaac agcatccgca
2160aagccaagat cttcccgaaa aagggcttcg atgctggtgc cgaagaaaag
cttgtgggct 2220gaagagttag cgcaggagga agaggatgag gaagatgtcg
gcaatgacag tggcgggtcc 2280ttgtccaagg ggagggcctc gaggaggaga
agcatgatgc tttga 23258774PRTNeurospora crassa 8Met Ala Arg Leu Asn
Glu Gln Ala Met Ser Ser Val Ala Leu Ser Thr1 5 10 15Asp Asn Leu Glu
Leu Leu Arg Arg Lys Phe Leu Arg Gln Asn Arg Asp 20 25 30Ile Ala Arg
Val Asn Ser Thr Gln Ser Leu Arg Ile Arg Gly Leu Glu 35 40 45Asn Glu
Cys Ala Arg Leu Leu Ser Glu Asn Leu Glu Leu Arg Gly Gln 50 55 60Val
Leu Arg Leu Glu Lys Glu Leu Gln Asp Asn Ala Ala Arg Arg Val65 70 75
80Ala Asp His Ala Leu Glu Val Lys Ala Lys Met Glu Thr Gln Leu Ala
85 90 95Glu Leu Ser Ser Leu Leu Ala Ser Leu Gly Glu Pro Pro Ser Lys
Arg 100 105 110Arg Leu Ser Glu Glu Arg Arg Tyr Ala Gln Pro Arg Pro
Ser Val His 115 120 125Arg Ser Pro Pro Leu Arg Arg Ala Arg Gln Glu
Ala Asp Gln Glu Leu 130 135 140Leu Ala Glu Gln Glu Gly Arg Leu Pro
Pro Ile Tyr Glu Asn Lys Thr145 150 155 160Tyr Ala Arg Ala Thr Met
Asn Ser Glu Glu Ile Leu Ala Leu Cys Met 165 170 175Gln Ala Asp Asp
Ser Asn Asp Ser Pro Asp Ile Gly Pro Pro Pro Val 180 185 190Ser Arg
Phe Val Glu Asp Asp Met Val Ile Pro Cys Ser Pro Ser Pro 195 200
205Asn Lys Asn Ala Glu Ala Glu Glu Thr Glu Thr Thr Glu Gln Val Glu
210 215 220Glu Ser Pro Arg Ala Leu Gln Val Pro Pro Ser Leu Ser Pro
Pro Lys225 230 235 240Leu Asp Tyr Asp Arg Arg Pro Asn Met Ile Leu
Phe Ser Pro Pro Lys 245 250 255Glu Ser Arg Val Ala Glu Pro Ser Lys
Met Phe Ser Pro Pro Pro Met 260 265 270Glu Pro Pro Lys Gln Ser Thr
Ser Ala Val Pro Ser Glu Thr Ile Arg 275 280 285Ala Gly Leu Lys Arg
Lys Leu Asn Gly Asp Asn Gln Asn Glu Pro Asn 290 295 300Lys Ala Thr
Lys Leu Gln Gln Gly Lys Glu Asn Gly Asn Glu Thr Gly305 310 315
320Ile Lys Lys Gly Leu Ser Ala Arg Asp Pro His Lys Arg Lys Ser Ile
325 330 335Lys Glu Thr Ala Thr Lys Pro Arg Ala Pro Leu Ser Ala Lys
Ser Thr 340 345 350Asn Glu His Ile Val Ser Pro Lys Lys Pro Ala Lys
Pro His Gln Val 355 360 365Ala Asp Asp Phe Lys Pro Val Lys Val His
Lys Ala Ser Lys Gly Lys 370 375 380Glu Lys Val Asp Leu Pro Ala Pro
Asp Lys Lys Ser Ala Val Glu Glu385 390 395 400Thr Gln Gly Asn Ser
Thr Ser Ala Phe Thr Lys Val Glu Ile Leu Pro 405 410 415Pro Ala Leu
Glu Pro Thr Pro Glu Val Ala Glu Ile Pro Glu Thr Asp 420 425 430Ile
Leu Ile Thr Pro Gly Thr Pro Glu Arg Ala Ser Glu Ser Thr Val 435 440
445Val Thr His Asp Thr Pro Pro Pro Ala His Ile Ser Ser Asn Gly Glu
450 455 460Thr Ser Arg Pro Ser Arg Arg Ala Arg Ala Ala Ile Ser Tyr
Thr Glu465 470 475 480Pro Asn Leu Arg Asp Lys Met Arg Arg Pro Thr
Lys Glu Leu Phe Asp 485 490 495Ala Val Ser Gly Glu Gly Lys Phe Leu
His Arg Pro Thr Ser Gln Gln 500 505 510Gln Gln Gln Gln Arg Lys Gly
Asp Glu Ser Ala Pro Thr Ser Val Ser 515 520 525Lys Val Lys Val Glu
Pro Ser Pro Ala Val Asp Ile Ser Ser Leu Thr 530 535 540Ser Ser Ala
Leu Phe Glu Lys Glu Lys Glu Lys Glu Pro Gln Pro Asp545 550 555
560Glu Gly Ile Leu Ser Pro Asn Gly Ile Leu Pro Ser Ser Val Asp Leu
565 570 575Gly Arg Arg Arg Arg Ala Ser Ser Phe Ser Thr Ala Ala Pro
Ala Met 580 585 590Thr Ile Pro Ser Val Gln Glu Gln Ser Thr Leu Asn
Leu Pro Ala Ala 595 600 605Asp Glu Thr Asp Glu Asn Ala Ala Val Glu
Ala Gln Ile Gln Lys Glu 610 615 620Leu Ser Asn Ser Ile Thr Thr Arg
Pro Arg Gly Gly Lys Gly Arg Gln625 630 635 640Ser Met Ser Arg Ser
Val Pro Thr Ile Pro Thr Glu Asn Tyr Glu His 645 650 655Glu Asp Ala
Gln Leu Ser Thr Asn Ser Ala Ser Val Asp Leu Tyr Asp 660 665 670Phe
Ala Ser Cys Ala Ser Pro Asp Ser Ala Ala Pro Gln Leu Glu Ala 675 680
685Thr Thr Gly Asp Val Pro Val Asn Lys Lys Ala Pro Lys Gly Ser Arg
690 695 700Arg Ala Ser Ser Ala Ala Ser Thr Glu Thr Thr Ala Thr Ala
Ser Ala705 710 715 720Lys Pro Arg Ser Ser Arg Lys Arg Ala Ser Met
Leu Val Pro Lys Lys 725 730 735Ser Leu Trp Ala Glu Glu Leu Ala Gln
Glu Glu Glu Asp Glu Glu Asp 740 745 750Val Gly Asn Asp Ser Gly Gly
Ser Leu Ser Lys Gly Arg Ala Ser Arg 755 760 765Arg Arg Ser Met Met
Leu 77091671DNAArabidopsis thaliana 9atggttcgag cgacggttct
gaatgtcggt gatcacgcca gtgaaggtgt gcgtactaac 60aaagctaaag gagagaaaat
ggttctggaa cctccgatga acagtgcaca aagacgaaag 120ttgggggata
ttactaattt gcagaatcag aagaatctaa tgaatcaggg agcgaagcat
180cagcaacaag ctatattaat ctcttctaaa gaaaacgctg aaaatcttca
aaaggcactg 240agaaattctt ctgaaaacac aaagctgatg aaagtcgtca
tggagagaga tggaatcaaa 300agtgatctga agaaacttag gattgaattt
cagaaggttc aagaacagaa tttgctactt 360gcccaggcta acactcgtat
cttggcgctg aaggtacttc agcacgaact tggttgcaag 420aatgggttag
tcatggccag gaaaatgctg cttaaggctc aagcaaatgc ttgtggtggg
480gcttgcaaaa cctttcagcc aaatgatgca gatcatgagc atgcttccgg
gagctccaac 540gctaactcat tgcaaagaaa tgagaaagcc aacagtaaaa
ggagagtttc tggaaggaag 600aatcccgcca attccgaggt attagatata
attggcagat cgggagagac atgtcagatg 660gaagacaaca ttgacaacaa
gaagttggtc tctgatagtg acaatgatgc tgaaaaccat 720ataaatgaca
atgtccaaag caaaagatat tgtgcaggaa gacagagtag cagttctaag
780actcgagaag ccagccaaac agaaaccttg caaaaggtgg ttgacgccaa
agaaattaag 840ggggatgcaa ggttttcttt gacaaagcat tctgactggt
taaaatctca agaacctgag 900ccatctgaaa gcctatacga gtcaaggttc
cctttgagaa ggcgttctgc ccggttaaaa 960tctcaagaac ctgagccatc
tgaaagcttc catgactcaa tagagacaac caagaggagg 1020aggtcggcaa
taaggtctgc tatgtttaat atccaagagc tgggcgttat tcaaaacttg
1080aacggtttac ctgatgatca agagattgct gcaaaggcca gatgctctgc
acgtgaacag 1140tctaccgggt ctaaacccga agcagtagaa ccacatgaca
caaaagagat aatcgggaaa 1200agcaggatat ctttgagaag acagtctgcg
aggtttaatt tccaagagct gggcgtgact 1260gaaaacttga atggtccaca
tgatgatcaa acgattgctg caaatgccag atgctgtgca 1320agtgaacagt
ctatcgggtc taaacccgaa gcagtagaac cacatgacat tgaagagaga
1380atcgggaaaa tcagagtctc ttcaagaaga caatctgcaa acattgaaac
tccgagagcc 1440atcaaagaac ctgcaaatcc gcctttgcat gatgacaatg
ttgaggagtc tagtcagata 1500tcatgttcag tttcaatgga gcttaaaaga
gaatcaaaga agaaaccaac aggcgacgaa 1560tcagaggaaa tgagaaaaac
aactgttgga agaccttcaa ggcaagctgc tgaaaaaatc 1620aaatcgtaca
aggaaccttc acttaaggag aagatgcgag ggggcttctg a
167110556PRTArabidopsis thaliana 10Met Val Arg Ala Thr Val Leu Asn
Val Gly Asp His Ala Ser Glu Gly1 5 10 15Val Arg Thr Asn Lys Ala Lys
Gly Glu Lys Met Val Leu Glu Pro Pro 20 25 30Met Asn Ser Ala Gln Arg
Arg Lys Leu Gly Asp Ile Thr Asn Leu Gln 35 40 45Asn Gln Lys Asn Leu
Met Asn Gln Gly Ala Lys His Gln Gln Gln Ala 50 55 60Ile Leu Ile Ser
Ser Lys Glu Asn Ala Glu Asn Leu Gln Lys Ala Leu65 70 75 80Arg Asn
Ser Ser Glu Asn Thr Lys Leu Met Lys Val Val Met Glu Arg 85 90 95Asp
Gly Ile Lys Ser Asp Leu Lys Lys Leu Arg Ile Glu Phe Gln Lys 100 105
110Val Gln Glu Gln Asn Leu Leu Leu Ala Gln Ala Asn Thr Arg Ile Leu
115 120 125Ala Leu Lys Val Leu Gln His Glu Leu Gly Cys Lys Asn Gly
Leu Val 130 135 140Met Ala Arg Lys Met Leu Leu Lys Ala Gln Ala Asn
Ala Cys Gly Gly145 150 155 160Ala Cys Lys Thr Phe Gln Pro Asn Asp
Ala Asp His Glu His Ala Ser 165 170 175Gly Ser Ser Asn Ala Asn Ser
Leu Gln Arg Asn Glu Lys Ala Asn Ser 180 185 190Lys Arg Arg Val Ser
Gly Arg Lys Asn Pro Ala Asn Ser Glu Val Leu 195 200 205Asp Ile Ile
Gly Arg Ser Gly Glu Thr Cys Gln Met Glu Asp Asn Ile 210 215 220Asp
Asn Lys Lys Leu Val Ser Asp Ser Asp Asn Asp Ala Glu Asn His225 230
235 240Ile Asn Asp Asn Val Gln Ser Lys Arg Tyr Cys Ala Gly Arg Gln
Ser 245 250 255Ser Ser Ser Lys Thr Arg Glu Ala Ser Gln Thr Glu Thr
Leu Gln Lys 260 265 270Val Val Asp Ala Lys Glu Ile Lys Gly Asp Ala
Arg Phe Ser Leu Thr 275 280 285Lys His Ser Asp Trp Leu Lys Ser Gln
Glu Pro Glu Pro Ser Glu Ser 290 295 300Leu Tyr Glu Ser Arg Phe Pro
Leu Arg Arg Arg Ser Ala Arg Leu Lys305 310 315 320Ser Gln Glu Pro
Glu Pro Ser Glu Ser Phe His Asp Ser Ile Glu Thr 325 330 335Thr Lys
Arg Arg Arg Ser Ala Ile Arg Ser Ala Met Phe Asn Ile Gln 340 345
350Glu Leu Gly Val Ile Gln Asn Leu Asn Gly Leu Pro Asp Asp Gln Glu
355 360 365Ile Ala Ala Lys Ala Arg Cys Ser Ala Arg Glu Gln Ser Thr
Gly Ser 370 375 380Lys Pro Glu Ala Val Glu Pro His Asp Thr Lys Glu
Ile Ile Gly Lys385 390 395 400Ser Arg Ile Ser Leu Arg Arg Gln Ser
Ala Arg Phe Asn Phe Gln Glu 405 410 415Leu Gly Val Thr Glu Asn Leu
Asn Gly Pro His Asp Asp Gln Thr Ile 420 425 430Ala Ala Asn Ala Arg
Cys Cys Ala Ser Glu Gln Ser Ile Gly Ser Lys 435 440 445Pro Glu Ala
Val Glu Pro His Asp Ile Glu Glu Arg Ile Gly Lys Ile 450 455 460Arg
Val Ser Ser Arg Arg Gln Ser Ala Asn Ile Glu Thr Pro Arg Ala465 470
475 480Ile Lys Glu Pro Ala Asn Pro Pro Leu His Asp Asp Asn Val Glu
Glu 485 490 495Ser Ser Gln Ile Ser Cys Ser Val Ser Met Glu Leu Lys
Arg Glu Ser 500 505 510Lys Lys Lys Pro Thr Gly Asp Glu Ser Glu Glu
Met Arg Lys Thr Thr 515 520 525Val Gly Arg Pro Ser Arg Gln Ala Ala
Glu Lys Ile Lys Ser Tyr Lys 530 535 540Glu Pro Ser Leu Lys Glu Lys
Met Arg Gly Gly Phe545 550 555111341DNAArabidopsis thaliana
11atggataaag aagagacgca gcagaaggaa aatatgctat tctcttccca ggaatatgct
60gcaaagcttc aaaaggcatt tcctcttcac tttaatcttg aaaacatgac actgatgaaa
120gctctagcac accgaaataa actcgtcgag ttgagcggta ttgagattca
gaaactgagg 180attaacttac ggagtgtgca ggaaaagaat ttgcagcttg
ctcaggcaaa cagtcagatg 240ttagcgctca aggatctcca gcatgaactt
ggctgcaaga atgctttact taaagtcaag 300aaacatcttg aggagcaagt
acttccacgt acacatcatg aatcgaaaga caaggtttca 360gcaagcgctt
ctgatgggga ttgcaaatcc tttcaggtgc atgacataaa acataaagat
420accaagagaa agcgaacaac aaggataaaa tcttcagtaa gtgccgacgt
caagccaata 480cctgtgaatg attctaacag taaagctaac cgtaaaagaa
gagtttctgg agtaatagat 540actactggta ttcccgaaga gatctgtcag
actgaagatg acattgataa gggggttgtc 600tctcgagggg taaaccaaga
tattgacaat gttgtcaaca agaagtttgt tcctgatgca 660gcaaacccgg
taaaagagag tgtgcatcgc aagaggcaat gtacacgaag gcaatctacc
720agatttgatg ttcaagaaac taaacaaacg gaaaagttgc ttgagatgga
tggtgccaaa 780gaaagtaaag aaaccgcaag cttctctttg agaagacggt
ctgctcggtt aaggcacgaa 840gaagctgaac catgtaaaag cttacatgag
ggagacgaag tcagggagac aatcaagagg 900agaagagtct ctttaagact
gtctgcaagg tttgatatac aagaaccgca tgtgactgaa 960acctcgaatg
ctgacgatgc aagaagcata gtaatcgaag aatctgctgg atcaagatcg
1020gaatctgtag aaccatccga aagcaggcat gaaacaaaag agataacccg
gaaacgcagt 1080ttctcaacga gaagacaatc aacaaagggt aaatctcaaa
ccgatgaagc cattaaagaa 1140atagcgacag acccatcttt ggtcaacacc
atagttcaag agtgtgatca ggaaacagaa 1200tcaaaggata agcctaaagc
tgatgaaaac gaagggatga caagaagatc atctgtggga 1260agaccatcga
gacatgccgc agagaaagtc caatcataca gagaagtctc acttagagta
1320aagatgcgac gaaaatgcta a 134112446PRTArabidopsis thaliana 12Met
Asp Lys Glu Glu Thr Gln Gln Lys Glu Asn Met Leu Phe Ser Ser1 5 10
15Gln Glu Tyr Ala Ala Lys Leu Gln Lys Ala Phe Pro Leu His Phe Asn
20 25 30Leu Glu Asn Met Thr Leu Met Lys Ala Leu Ala His Arg Asn Lys
Leu 35 40 45Val Glu Leu Ser Gly Ile Glu Ile Gln Lys Leu Arg Ile Asn
Leu Arg 50 55 60Ser Val Gln Glu Lys Asn Leu Gln Leu Ala Gln Ala Asn
Ser Gln Met65 70 75 80Leu Ala Leu Lys Asp Leu Gln His Glu Leu Gly
Cys Lys Asn Ala Leu 85 90 95Leu Lys Val Lys Lys His Leu Glu Glu Gln
Val Leu Pro Arg Thr His 100 105 110His Glu Ser Lys Asp Lys Val Ser
Ala Ser Ala Ser Asp Gly Asp Cys 115 120 125Lys Ser Phe Gln Val His
Asp Ile Lys His Lys Asp Thr Lys Arg Lys 130 135 140Arg Thr Thr Arg
Ile Lys Ser Ser Val Ser Ala Asp Val Lys Pro Ile145 150 155 160Pro
Val Asn Asp Ser Asn Ser Lys Ala Asn Arg Lys Arg Arg Val Ser 165 170
175Gly Val Ile Asp Thr Thr Gly Ile Pro Glu Glu Ile Cys Gln Thr Glu
180 185 190Asp Asp Ile Asp Lys Gly Val Val Ser Arg Gly Val Asn Gln
Asp Ile 195 200 205Asp Asn Val Val Asn Lys Lys Phe Val Pro Asp Ala
Ala Asn Pro Val 210 215 220Lys Glu Ser Val His Arg Lys Arg Gln Cys
Thr Arg Arg Gln Ser Thr225 230 235 240Arg Phe Asp Val Gln Glu Thr
Lys Gln Thr Glu Lys Leu Leu Glu Met 245 250 255Asp Gly Ala Lys Glu
Ser Lys Glu Thr Ala Ser Phe Ser Leu Arg Arg 260 265 270Arg Ser Ala
Arg Leu Arg His Glu Glu Ala Glu Pro Cys Lys Ser Leu 275 280 285His
Glu Gly Asp Glu Val Arg Glu Thr Ile Lys Arg Arg Arg Val Ser 290 295
300Leu Arg Leu Ser Ala Arg Phe Asp Ile Gln Glu Pro His Val Thr
Glu305 310 315 320Thr Ser Asn Ala Asp Asp Ala Arg Ser Ile Val Ile
Glu Glu Ser Ala 325 330 335Gly Ser Arg Ser Glu Ser Val Glu Pro Ser
Glu Ser Arg His Glu Thr 340 345 350Lys Glu Ile Thr Arg Lys Arg Ser
Phe Ser Thr Arg Arg Gln Ser Thr 355
360 365Lys Gly Lys Ser Gln Thr Asp Glu Ala Ile Lys Glu Ile Ala Thr
Asp 370 375 380Pro Ser Leu Val Asn Thr Ile Val Gln Glu Cys Asp Gln
Glu Thr Glu385 390 395 400Ser Lys Asp Lys Pro Lys Ala Asp Glu Asn
Glu Gly Met Thr Arg Arg 405 410 415Ser Ser Val Gly Arg Pro Ser Arg
His Ala Ala Glu Lys Val Gln Ser 420 425 430Tyr Arg Glu Val Ser Leu
Arg Val Lys Met Arg Arg Lys Cys 435 440 445131554DNAmouse
13atggctaagg aaaggtgtca gaaaaggtcc tttcaagata cccttgaaga cattaagaat
60cgaatgaaag aaaaaaggaa taaaaatttg gcggggattg ggaaacgcaa gtcctttatt
120gttgcaccgg gccaagtacc cactaacact gctacactac tgagatatta
ccaagataac 180aacaggttgt tagtcttggc tttggaaaat gagaaatcca
aagtgagaga agcacaggat 240gtcatcctgc aactgagaaa agaatgctac
taccttactt gtcagctgta tgcattgaaa 300gagaagctaa cttcccgaca
aagtgaagaa actactcaga actggaaagg acgtccctca 360gacgtggtct
ccagcattga caatacgacc agggacttgt cagggaagtc cttacagcaa
420attgctgttg aagaaactga ttgtccttac caaaccacag aaccaagtcc
tgctgttact 480ccagagacac agggttgcga ttttgattca ggtaaagttg
agtctactga tgaagtctta 540cccagaacta tatctatccg tcgccattta
aggaaagatt ttagtaatat aagccactcc 600acgactttgg aggattgtaa
agccagtcca agagtggcac agtctctgga agttaaagga 660agtagatgta
gagaagtaac cgtaaccctg cacagacttg aaaatgtttg tctgtggaac
720aaagaccaaa ttagcttatg ttctagactg attaacccag caaagattac
tgaaacagaa 780gtcattttat catctaaacc tgaacaaata gaaagcaagc
ataaacgtgc acgaaaaaga 840agagcagagc aaagaagaac caagcagaga
tgcaaatcaa aatcctcatt gaggagtaag 900gggaacaaaa acaaagataa
gcagggttta ccccctacta cactggatgg aggtattggt 960tcctgtgatg
cttacgattt taatctaaaa gggacggtcc accccacccc tttccgacaa
1020aaaatgaaca atggctgcaa caaagaaacg gatagcagca actcagaagt
gagtgacctc 1080gaatgcagta cctctgagga tgagtctgat gacctctacc
tgcctccctc caagcgcttg 1140cgagactaca gagagtcaga gagagcagtt
accaggcctc ggtctaaaag aggacttcag 1200tacccagatg ggaaagagag
gaaggaggtg ctgccatcta cagctcctac tggtatccca 1260cctgagactc
aagagtcacc tcgttgtagc ctaaaggatg tcaccaatat cctgcagtgt
1320cctagagtga agatcaggaa gccttctctg cctccaaagc ggcgtgaaga
cagcccagca 1380gtggctctga ctaaacgcag gtgtagcacc atcaaaagct
ataaagagcc aacactcgct 1440tcaaagctaa gaagagggga ccctttcacg
gacttgtgtt tcttgaattc tcctattttc 1500aagcagaaaa ggggtatgag
atgtcctaaa agaagaacca agcaaacaca gtaa 155414517PRTmosue 14Met Ala
Lys Glu Arg Cys Gln Lys Arg Ser Phe Gln Asp Thr Leu Glu1 5 10 15Asp
Ile Lys Asn Arg Met Lys Glu Lys Arg Asn Lys Asn Leu Ala Gly 20 25
30Ile Gly Lys Arg Lys Ser Phe Ile Val Ala Pro Gly Gln Val Pro Thr
35 40 45Asn Thr Ala Thr Leu Leu Arg Tyr Tyr Gln Asp Asn Asn Arg Leu
Leu 50 55 60Val Leu Ala Leu Glu Asn Glu Lys Ser Lys Val Arg Glu Ala
Gln Asp65 70 75 80Val Ile Leu Gln Leu Arg Lys Glu Cys Tyr Tyr Leu
Thr Cys Gln Leu 85 90 95Tyr Ala Leu Lys Glu Lys Leu Thr Ser Arg Gln
Ser Glu Glu Thr Thr 100 105 110Gln Asn Trp Lys Gly Arg Pro Ser Asp
Val Val Ser Ser Ile Asp Asn 115 120 125Thr Thr Arg Asp Leu Ser Gly
Lys Ser Leu Gln Gln Ile Ala Val Glu 130 135 140Glu Thr Asp Cys Pro
Tyr Gln Thr Thr Glu Pro Ser Pro Ala Val Thr145 150 155 160Pro Glu
Thr Gln Gly Cys Asp Phe Asp Ser Gly Lys Val Glu Ser Thr 165 170
175Asp Glu Val Leu Pro Arg Thr Ile Ser Ile Arg Arg His Leu Arg Lys
180 185 190Asp Phe Ser Asn Ile Ser His Ser Thr Thr Leu Glu Asp Cys
Lys Ala 195 200 205Ser Pro Arg Val Ala Gln Ser Leu Glu Val Lys Gly
Ser Arg Cys Arg 210 215 220Glu Val Thr Val Thr Leu His Arg Leu Glu
Asn Val Cys Leu Trp Asn225 230 235 240Lys Asp Gln Ile Ser Leu Cys
Ser Arg Leu Ile Asn Pro Ala Lys Ile 245 250 255Thr Glu Thr Glu Val
Ile Leu Ser Ser Lys Pro Glu Gln Ile Glu Ser 260 265 270Lys His Lys
Arg Ala Arg Lys Arg Arg Ala Glu Gln Arg Arg Thr Lys 275 280 285Gln
Arg Cys Lys Ser Lys Ser Ser Leu Arg Ser Lys Gly Asn Lys Asn 290 295
300Lys Asp Lys Gln Gly Leu Pro Pro Thr Thr Leu Asp Gly Gly Ile
Gly305 310 315 320Ser Cys Asp Ala Tyr Asp Phe Asn Leu Lys Gly Thr
Val His Pro Thr 325 330 335Pro Phe Arg Gln Lys Met Asn Asn Gly Cys
Asn Lys Glu Thr Asp Ser 340 345 350Ser Asn Ser Glu Val Ser Asp Leu
Glu Cys Ser Thr Ser Glu Asp Glu 355 360 365Ser Asp Asp Leu Tyr Leu
Pro Pro Ser Lys Arg Leu Arg Asp Tyr Arg 370 375 380Glu Ser Glu Arg
Ala Val Thr Arg Pro Arg Ser Lys Arg Gly Leu Gln385 390 395 400Tyr
Pro Asp Gly Lys Glu Arg Lys Glu Val Leu Pro Ser Thr Ala Pro 405 410
415Thr Gly Ile Pro Pro Glu Thr Gln Glu Ser Pro Arg Cys Ser Leu Lys
420 425 430Asp Val Thr Asn Ile Leu Gln Cys Pro Arg Val Lys Ile Arg
Lys Pro 435 440 445Ser Leu Pro Pro Lys Arg Arg Glu Asp Ser Pro Ala
Val Ala Leu Thr 450 455 460Lys Arg Arg Cys Ser Thr Ile Lys Ser Tyr
Lys Glu Pro Thr Leu Ala465 470 475 480Ser Lys Leu Arg Arg Gly Asp
Pro Phe Thr Asp Leu Cys Phe Leu Asn 485 490 495Ser Pro Ile Phe Lys
Gln Lys Arg Gly Met Arg Cys Pro Lys Arg Arg 500 505 510Thr Lys Gln
Thr Gln 515153495DNAmouse 15atggagtacc cagggataaa agttgacact
gttacctctg gaattcagag acgagtgaag 60ggcagaattg caaagacaaa tttgaatgtt
tctcttgctt caaagatcaa agcaaaaata 120ttaaacaatt cttctatttt
caagatctct ctaaagcaca acaacagagc attagcgcgg 180gcccttagta
aagagaaaga gaattctcga agaattacta ccgaaaagat gcaattacag
240aaagaagtag agaaactgaa ttttgagaat acctttcttc gcttaaagtt
aaataccttg 300aataagaagc ttgtagaaat agaatcgcat gtgagcaatg
atttgttaac tgcaattgaa 360ataagcagtc tttctgagtt ccaccaaggt
tcttttctcc tgtcagctac caagaaacaa 420aggaacagta agcagtgcaa
gcctgcgcat cttccatatg caagagttct gttaacttca 480gaaaatgatg
atgatgatgg tgctgatgat aaatggcaga caaagtgtaa caacagaact
540atatcaaaga cctcacctga tagtacctct tcagtatcaa gacaaccttc
atccttacat 600cagtgcaatt tgaaagcatt ccctcctaaa gaagataatc
agaagacatg tgggtcaggt 660catttagaac atacttcaag tgttgatata
cttcctaatg agagccactc agatcaaagt 720cctaagagtt ctctgagtga
gatgaaaact gctccatctc ccagcctcag aagggaaaaa 780ttatcacatg
gtaatgtgac tatgaggaag aagtgtgtgt cttcaactcc agacattctg
840tatgtgacag atttagatca ccaaccaact tcaagtccag gatcaaattg
gaataatgag 900atacatggtc atactaatga aaccagcaat aacacgcaaa
gaaatgccga gtgttttctt 960gacttacctt ctgagtcttc cagtgagcct
gacgcaaagc gcatggagct agtgcagaag 1020aacaccgata gctttcactt
ccagaaaact gtatatgatg ccgctgatat ggagttaact 1080gctactgaca
taggcaagat tgtagcagtt tcaaaaagca agaaaaatca aaataagaaa
1140aaggcagact gtagaaagga gactttcaga aaagtgaaag gtgcaagctc
tgataaaaag 1200agagaaagct caaagagaga atgtaaagat ggttcagaag
taggtgctga ggaagaggct 1260gatgcagcca gagcagaaag aggcgctggt
gtcctggatg gcagagggga ttcagaagag 1320ccaaactgca tttccagtac
tgagcagcca tctcaggtaa acacgcaaaa gaaaagaacc 1380ctccagaaca
gctcagatca ggagaacatt caaaatacga agaggaggca aacatatacg
1440acagatgagc aagaggaaac aaaccctttc tccagacatt cagtcaaatt
tcttcaagat 1500ggtaaatttg atctgtgtca gaaaacccta catcataatt
taagtaagcc ttctcgacag 1560acatttgtga ttcgtaagtc agaaaaagat
aacttatttc caaatcaaga agataaagac 1620accatttctg aaaacctaga
agttacaaat gaatttcata tagatgatct ttccatcgaa 1680gctaatgaaa
atgtatgtga ccatgagact cagacaatgt tggacttgaa aaagtctgtc
1740agtgctcaac aaaatcaaac aaaaataaat aagactaagc agaaaataaa
tcgaaggaca 1800aaaataattt ctgtcatgag ccaagtatat gaggacaatg
ataaagatat tcacgtccta 1860gaaaaagaca actttccctt tcatacccaa
gcaaataaag aaaccaccag tggaaaccta 1920gaaagttcaa aagaatttga
atcacctctt cttttcacaa gagacaacgg aagcttacgt 1980gactgtaaga
cccagaatgt tctggatctg cacaagcaaa ttcctgatct ataccctgat
2040cggaatgagt cccagattag caaaatccct aggcaaaaag taaatcgcaa
gacagaagta 2100atttctggag tgaaatgttt tagtaatgac caaggtgttc
attgctcaga aaaggataag 2160tctttgttac tacaaaagga taaagacttc
ccaggaactt taaaagactt aagtgagttt 2220gatacgcctg ctttttgtaa
caaagatagt gcaaagtcgt gtgattataa gtctgaaatg 2280ctcttggggt
tgaaaaaaca tgaccctaat atgcaacctg cttgtcaaga tgattcaaaa
2340gcaggtaaga aacttagaca aaaggtaaat cgaaaaacag aaataatttc
taaaatcacc 2400caaatacatg aaaatgatag aggaagtaca catgactcat
taaataagaa gctctgtcag 2460aaggttaata tatcaaaaat catttctcaa
atgaaccaaa tatatgagac tattaatgaa 2520gatggaaatg gctttaaaag
ctctatcaaa gattgcgaag atattaaaag ttgtgacttt 2580ggggaaatca
acagtaataa aaaggaaaat tatgatccaa ttcaagatcc ttgcacactg
2640gttaaaaaaa caaagagaaa gggatcatgt aaagcaggga gcagtttggc
aggagctaag 2700aacaggtgtg gtttgcagtt aacagactct tcccaggtac
agtctgtccc cttagactct 2760ggcttaagac accatccaaa cgaagcagat
tctggtcctg gagagcagac taacctgcca 2820aagatgcaga aacaaagcgc
tgggaggtca ctgggagatg ctttctctgt gagtctggga 2880aaagaaggaa
gccgcccagc caaagcagtt agtaaaatga cacccaaatc aaagaagaga
2940aagctccctc tcggttgttc tcctgaaacc cacgggacgg tggagataac
acccaacact 3000gacctcgcta aggctgttga ctcccaacag actgagaagg
agaactattt ggagaaggag 3060aaaattgcca agaggaagcc agatttttgt
acaaaggtgt tgaaaccttt atctgagaca 3120tgttcatcta acataaagaa
ttcttccttg gacagtatgt gtaagagttc gctacctttg 3180agtatttctt
ctagaaaaac cctgatgctg gaagaaagtt cttccctgga gagtacatgc
3240atctttcaag taggtgatgc cgctcatgag aagataacga caggcacacg
taatccccac 3300cacaggacac agaagtcgac accgggtagc agaacgtccc
tggtcttggt ggataccagt 3360tctgtttcag ataccaaccc tgctaacccc
gagaatgagt cagaagggca gtcttcacac 3420ccaatgagaa ggaaaagaca
gtgcgtccct ctcaacctga cagagccaag ccttagaagc 3480aagatgagga gataa
3495161164PRTmouse 16Met Glu Tyr Pro Gly Ile Lys Val Asp Thr Val
Thr Ser Gly Ile Gln1 5 10 15Arg Arg Val Lys Gly Arg Ile Ala Lys Thr
Asn Leu Asn Val Ser Leu 20 25 30Ala Ser Lys Ile Lys Ala Lys Ile Leu
Asn Asn Ser Ser Ile Phe Lys 35 40 45Ile Ser Leu Lys His Asn Asn Arg
Ala Leu Ala Arg Ala Leu Ser Lys 50 55 60Glu Lys Glu Asn Ser Arg Arg
Ile Thr Thr Glu Lys Met Gln Leu Gln65 70 75 80Lys Glu Val Glu Lys
Leu Asn Phe Glu Asn Thr Phe Leu Arg Leu Lys 85 90 95Leu Asn Thr Leu
Asn Lys Lys Leu Val Glu Ile Glu Ser His Val Ser 100 105 110Asn Asp
Leu Leu Thr Ala Ile Glu Ile Ser Ser Leu Ser Glu Phe His 115 120
125Gln Gly Ser Phe Leu Leu Ser Ala Thr Lys Lys Gln Arg Asn Ser Lys
130 135 140Gln Cys Lys Pro Ala His Leu Pro Tyr Ala Arg Val Leu Leu
Thr Ser145 150 155 160Glu Asn Asp Asp Asp Asp Gly Ala Asp Asp Lys
Trp Gln Thr Lys Cys 165 170 175Asn Asn Arg Thr Ile Ser Lys Thr Ser
Pro Asp Ser Thr Ser Ser Val 180 185 190Ser Arg Gln Pro Ser Ser Leu
His Gln Cys Asn Leu Lys Ala Phe Pro 195 200 205Pro Lys Glu Asp Asn
Gln Lys Thr Cys Gly Ser Gly His Leu Glu His 210 215 220Thr Ser Ser
Val Asp Ile Leu Pro Asn Glu Ser His Ser Asp Gln Ser225 230 235
240Pro Lys Ser Ser Leu Ser Glu Met Lys Thr Ala Pro Ser Pro Ser Leu
245 250 255Arg Arg Glu Lys Leu Ser His Gly Asn Val Thr Met Arg Lys
Lys Cys 260 265 270Val Ser Ser Thr Pro Asp Ile Leu Tyr Val Thr Asp
Leu Asp His Gln 275 280 285Pro Thr Ser Ser Pro Gly Ser Asn Trp Asn
Asn Glu Ile His Gly His 290 295 300Thr Asn Glu Thr Ser Asn Asn Thr
Gln Arg Asn Ala Glu Cys Phe Leu305 310 315 320Asp Leu Pro Ser Glu
Ser Ser Ser Glu Pro Asp Ala Lys Arg Met Glu 325 330 335Leu Val Gln
Lys Asn Thr Asp Ser Phe His Phe Gln Lys Thr Val Tyr 340 345 350Asp
Ala Ala Asp Met Glu Leu Thr Ala Thr Asp Ile Gly Lys Ile Val 355 360
365Ala Val Ser Lys Ser Lys Lys Asn Gln Asn Lys Lys Lys Ala Asp Cys
370 375 380Arg Lys Glu Thr Phe Arg Lys Val Lys Gly Ala Ser Ser Asp
Lys Lys385 390 395 400Arg Glu Ser Ser Lys Arg Glu Cys Lys Asp Gly
Ser Glu Val Gly Ala 405 410 415Glu Glu Glu Ala Asp Ala Ala Arg Ala
Glu Arg Gly Ala Gly Val Leu 420 425 430Asp Gly Arg Gly Asp Ser Glu
Glu Pro Asn Cys Ile Ser Ser Thr Glu 435 440 445Gln Pro Ser Gln Val
Asn Thr Gln Lys Lys Arg Thr Leu Gln Asn Ser 450 455 460Ser Asp Gln
Glu Asn Ile Gln Asn Thr Lys Arg Arg Gln Thr Tyr Thr465 470 475
480Thr Asp Glu Gln Glu Glu Thr Asn Pro Phe Ser Arg His Ser Val Lys
485 490 495Phe Leu Gln Asp Gly Lys Phe Asp Leu Cys Gln Lys Thr Leu
His His 500 505 510Asn Leu Ser Lys Pro Ser Arg Gln Thr Phe Val Ile
Arg Lys Ser Glu 515 520 525Lys Asp Asn Leu Phe Pro Asn Gln Glu Asp
Lys Asp Thr Ile Ser Glu 530 535 540Asn Leu Glu Val Thr Asn Glu Phe
His Ile Asp Asp Leu Ser Ile Glu545 550 555 560Ala Asn Glu Asn Val
Cys Asp His Glu Thr Gln Thr Met Leu Asp Leu 565 570 575Lys Lys Ser
Val Ser Ala Gln Gln Asn Gln Thr Lys Ile Asn Lys Thr 580 585 590Lys
Gln Lys Ile Asn Arg Arg Thr Lys Ile Ile Ser Val Met Ser Gln 595 600
605Val Tyr Glu Asp Asn Asp Lys Asp Ile His Val Leu Glu Lys Asp Asn
610 615 620Phe Pro Phe His Thr Gln Ala Asn Lys Glu Thr Thr Ser Gly
Asn Leu625 630 635 640Glu Ser Ser Lys Glu Phe Glu Ser Pro Leu Leu
Phe Thr Arg Asp Asn 645 650 655Gly Ser Leu Arg Asp Cys Lys Thr Gln
Asn Val Leu Asp Leu His Lys 660 665 670Gln Ile Pro Asp Leu Tyr Pro
Asp Arg Asn Glu Ser Gln Ile Ser Lys 675 680 685Ile Pro Arg Gln Lys
Val Asn Arg Lys Thr Glu Val Ile Ser Gly Val 690 695 700Lys Cys Phe
Ser Asn Asp Gln Gly Val His Cys Ser Glu Lys Asp Lys705 710 715
720Ser Leu Leu Leu Gln Lys Asp Lys Asp Phe Pro Gly Thr Leu Lys Asp
725 730 735Leu Ser Glu Phe Asp Thr Pro Ala Phe Cys Asn Lys Asp Ser
Ala Lys 740 745 750Ser Cys Asp Tyr Lys Ser Glu Met Leu Leu Gly Leu
Lys Lys His Asp 755 760 765Pro Asn Met Gln Pro Ala Cys Gln Asp Asp
Ser Lys Ala Gly Lys Lys 770 775 780Leu Arg Gln Lys Val Asn Arg Lys
Thr Glu Ile Ile Ser Lys Ile Thr785 790 795 800Gln Ile His Glu Asn
Asp Arg Gly Ser Thr His Asp Ser Leu Asn Lys 805 810 815Lys Leu Cys
Gln Lys Val Asn Ile Ser Lys Ile Ile Ser Gln Met Asn 820 825 830Gln
Ile Tyr Glu Thr Ile Asn Glu Asp Gly Asn Gly Phe Lys Ser Ser 835 840
845Ile Lys Asp Cys Glu Asp Ile Lys Ser Cys Asp Phe Gly Glu Ile Asn
850 855 860Ser Asn Lys Lys Glu Asn Tyr Asp Pro Ile Gln Asp Pro Cys
Thr Leu865 870 875 880Val Lys Lys Thr Lys Arg Lys Gly Ser Cys Lys
Ala Gly Ser Ser Leu 885 890 895Ala Gly Ala Lys Asn Arg Cys Gly Leu
Gln Leu Thr Asp Ser Ser Gln 900 905 910Val Gln Ser Val Pro Leu Asp
Ser Gly Leu Arg His His Pro Asn Glu 915 920 925Ala Asp Ser Gly Pro
Gly Glu Gln Thr Asn Leu Pro Lys Met Gln Lys 930 935 940Gln Ser Ala
Gly Arg Ser Leu Gly Asp Ala Phe Ser Val Ser Leu Gly945 950 955
960Lys Glu Gly Ser Arg Pro Ala Lys Ala Val Ser Lys Met Thr Pro Lys
965 970 975Ser Lys Lys Arg Lys Leu Pro Leu Gly Cys Ser Pro Glu Thr
His Gly 980 985 990Thr Val Glu Ile Thr Pro Asn Thr Asp Leu Ala Lys
Ala Val Asp Ser 995 1000 1005Gln Gln Thr Glu Lys Glu Asn Tyr Leu
Glu Lys Glu Lys Ile Ala 1010 1015
1020Lys Arg Lys Pro Asp Phe Cys Thr Lys Val Leu Lys Pro Leu Ser
1025 1030 1035Glu Thr Cys Ser Ser Asn Ile Lys Asn Ser Ser Leu Asp
Ser Met 1040 1045 1050Cys Lys Ser Ser Leu Pro Leu Ser Ile Ser Ser
Arg Lys Thr Leu 1055 1060 1065Met Leu Glu Glu Ser Ser Ser Leu Glu
Ser Thr Cys Ile Phe Gln 1070 1075 1080Val Gly Asp Ala Ala His Glu
Lys Ile Thr Thr Gly Thr Arg Asn 1085 1090 1095Pro His His Arg Thr
Gln Lys Ser Thr Pro Gly Ser Arg Thr Ser 1100 1105 1110Leu Val Leu
Val Asp Thr Ser Ser Val Ser Asp Thr Asn Pro Ala 1115 1120 1125Asn
Pro Glu Asn Glu Ser Glu Gly Gln Ser Ser His Pro Met Arg 1130 1135
1140Arg Lys Arg Gln Cys Val Pro Leu Asn Leu Thr Glu Pro Ser Leu
1145 1150 1155Arg Ser Lys Met Arg Arg 1160171584DNAHomo sapiens
17atggccaagg aaagatgcct gaaaaagtcc tttcaagata gtcttgaaga cataaagaag
60cgaatgaaag agaaaaggaa taaaaacttg gcagagattg gcaaacgcag gtcttttata
120gctgcaccat gccaaataat caccaacact tctacactgc tgaaaaatta
ccaagacaac 180aacaaaatgt tagttttagc tttggaaaat gaaaaatcca
aagtgaaaga agcccaagat 240atcatcctac agctgagaaa agaatgttac
tatctcacat gtcagctata tgcattgaaa 300ggaaaactta catcacaaca
aacagtagaa cctgctcaga accaggaaat atgttcctct 360ggaatggacc
ccaatagtga tgacagctcc agaaatttat ttgtgaagga tttaccgcaa
420attcctcttg aagaaactga acttccagga caaggagaat catttcaaat
agaagatcag 480atacctacta ttcctcaaga cacactggga gttgattttg
attcaggtga agctaagtct 540actgataatg tcttacctag aactgtatct
gttcgtagca gtttaaagaa acattgtaac 600agtatatgtc agtttgatag
cttggatgat tttgaaacca gtcatttggc agggaagtct 660tttgaattcg
aaagagttgg atttttagac ccactagtaa acatgcacat acctgaaaat
720gtacaacaca atgcttgtca atggagcaag gaccaagtta acttatcacc
aaagctgatt 780cagccaggaa cgtttactaa aacaaaagaa gacattttag
aatctaaatc tgaacaaact 840aaaagtaagc aaagagatac acaagaaaga
aaaagagaag agaaaagaaa agctaacagg 900agaaaatcaa aacgtatgtc
aaaatataaa gagaataaaa gcgaaaataa aaaaactgtt 960ccccaaaaaa
aaatgcacaa atctgtcagt tccaatgatg cttacaattt taatttggaa
1020gagggtgttc atcttactcc tttccgacaa aaagtgagca atgactctaa
tagagaagaa 1080aacaacgagt ctgaagtgag cctctgtgaa tcaagtggtt
caggagatga ttccgatgac 1140ctctatttgc ccacttgcaa gtacattcag
aatcccacga gcaattcaga tagaccagtc 1200accaggcctc tagctaaaag
agcactgaaa tacacagatg aaaaagagac ggagggttct 1260aagccaacaa
aaactcctac cactacacca cctgaaactc agcagtcacc tcatcttagc
1320ctgaaggata tcaccaatgt ctccttgtat cctgttgtga aaatcagaag
actttctctt 1380tctccaaaaa agaataaagc aagcccagca gtggctctgc
ctaaacgtag gtgcacagcc 1440agcgtgaact ataaggagcc caccctcgct
tcgaaactga gaagagggga cccttttaca 1500gatttgtgtt ttttgaattc
tcctattttc aagcagaaaa aggatttgag acgttctaaa 1560aaaagtatga
aacaaataca atga 158418527PRTHomo sapiens 18Met Ala Lys Glu Arg Cys
Leu Lys Lys Ser Phe Gln Asp Ser Leu Glu1 5 10 15Asp Ile Lys Lys Arg
Met Lys Glu Lys Arg Asn Lys Asn Leu Ala Glu 20 25 30Ile Gly Lys Arg
Arg Ser Phe Ile Ala Ala Pro Cys Gln Ile Ile Thr 35 40 45Asn Thr Ser
Thr Leu Leu Lys Asn Tyr Gln Asp Asn Asn Lys Met Leu 50 55 60Val Leu
Ala Leu Glu Asn Glu Lys Ser Lys Val Lys Glu Ala Gln Asp65 70 75
80Ile Ile Leu Gln Leu Arg Lys Glu Cys Tyr Tyr Leu Thr Cys Gln Leu
85 90 95Tyr Ala Leu Lys Gly Lys Leu Thr Ser Gln Gln Thr Val Glu Pro
Ala 100 105 110Gln Asn Gln Glu Ile Cys Ser Ser Gly Met Asp Pro Asn
Ser Asp Asp 115 120 125Ser Ser Arg Asn Leu Phe Val Lys Asp Leu Pro
Gln Ile Pro Leu Glu 130 135 140Glu Thr Glu Leu Pro Gly Gln Gly Glu
Ser Phe Gln Ile Glu Asp Gln145 150 155 160Ile Pro Thr Ile Pro Gln
Asp Thr Leu Gly Val Asp Phe Asp Ser Gly 165 170 175Glu Ala Lys Ser
Thr Asp Asn Val Leu Pro Arg Thr Val Ser Val Arg 180 185 190Ser Ser
Leu Lys Lys His Cys Asn Ser Ile Cys Gln Phe Asp Ser Leu 195 200
205Asp Asp Phe Glu Thr Ser His Leu Ala Gly Lys Ser Phe Glu Phe Glu
210 215 220Arg Val Gly Phe Leu Asp Pro Leu Val Asn Met His Ile Pro
Glu Asn225 230 235 240Val Gln His Asn Ala Cys Gln Trp Ser Lys Asp
Gln Val Asn Leu Ser 245 250 255Pro Lys Leu Ile Gln Pro Gly Thr Phe
Thr Lys Thr Lys Glu Asp Ile 260 265 270Leu Glu Ser Lys Ser Glu Gln
Thr Lys Ser Lys Gln Arg Asp Thr Gln 275 280 285Glu Arg Lys Arg Glu
Glu Lys Arg Lys Ala Asn Arg Arg Lys Ser Lys 290 295 300Arg Met Ser
Lys Tyr Lys Glu Asn Lys Ser Glu Asn Lys Lys Thr Val305 310 315
320Pro Gln Lys Lys Met His Lys Ser Val Ser Ser Asn Asp Ala Tyr Asn
325 330 335Phe Asn Leu Glu Glu Gly Val His Leu Thr Pro Phe Arg Gln
Lys Val 340 345 350Ser Asn Asp Ser Asn Arg Glu Glu Asn Asn Glu Ser
Glu Val Ser Leu 355 360 365Cys Glu Ser Ser Gly Ser Gly Asp Asp Ser
Asp Asp Leu Tyr Leu Pro 370 375 380Thr Cys Lys Tyr Ile Gln Asn Pro
Thr Ser Asn Ser Asp Arg Pro Val385 390 395 400Thr Arg Pro Leu Ala
Lys Arg Ala Leu Lys Tyr Thr Asp Glu Lys Glu 405 410 415Thr Glu Gly
Ser Lys Pro Thr Lys Thr Pro Thr Thr Thr Pro Pro Glu 420 425 430Thr
Gln Gln Ser Pro His Leu Ser Leu Lys Asp Ile Thr Asn Val Ser 435 440
445Leu Tyr Pro Val Val Lys Ile Arg Arg Leu Ser Leu Ser Pro Lys Lys
450 455 460Asn Lys Ala Ser Pro Ala Val Ala Leu Pro Lys Arg Arg Cys
Thr Ala465 470 475 480Ser Val Asn Tyr Lys Glu Pro Thr Leu Ala Ser
Lys Leu Arg Arg Gly 485 490 495Asp Pro Phe Thr Asp Leu Cys Phe Leu
Asn Ser Pro Ile Phe Lys Gln 500 505 510Lys Lys Asp Leu Arg Arg Ser
Lys Lys Ser Met Lys Gln Ile Gln 515 520 525193798DNAHomo sapiens
19atggagtgcc cagtgatgga aactggctca ctttttacct caggaattaa gagacatttg
60aaagacaaaa gaatttcaaa gactactaag ttgaatgttt ctcttgcttc aaaaataaaa
120acaaaaatac taaataattc ttctattttc aaaatatctt taaagcacaa
caacagggca 180ttagctcagg ctcttagtag agaaaaagag aattctcgaa
gaattacaac tgaaaagatg 240ctattgcaaa aagaagtaga gaaactgaat
tttgagaaca catttcttcg cctaaagcta 300aataacttga ataagaagct
tatagacata gaagctctca tgaacaataa cttgataact 360gcaactgaaa
tgagcagtct ttctgagttc catcagagtt cctttctact gtcagctagc
420aagaagaaac gagttagtaa acagtgcaag ttgatgcgtc ttccatttgc
aagggttcca 480ttaacttcaa atgatgatga agatgaagat aaagagaaaa
tgcagtgtga caacaatatt 540aaatcaaaga cattacctga tattccctct
tcaggatcaa caacacaacc tttatcaact 600caggataatt cggaagtgtt
atttcttaaa gaaaataatc aaaatgtata tggtttagat 660gattcagaac
atatttcttc tatagttgat gtacctccca gagaaagcca ttcccactca
720gaccaaagtt ctaagacttc tctaatgagt gagatgagaa acgcccagtc
tattggccgc 780agatgggaga aaccatctcc tagtaatgtg actgaaagga
agaagcgtgg gtcatcttgg 840gaatcaaata atctttctgc agacactccc
tgtgcaacag ttttagataa acaacacatt 900tcaagtccag aattaaattg
caataatgag ataaatggtc atactaatga aacaaatact 960gaaatgcaaa
gaaataaaca ggatcttcct ggcttatctt ctgagtctgc cagagaacct
1020aatgcagagt gcatgaatca aattgaggat aatgatgact ttcaattgca
gaaaactgtg 1080tatgatgctg acatggattt aactgctagt gaagtcagca
aaattgtcac agtctcaaca 1140ggcattaaaa agaaaagtaa taaaaaaaca
aatgaacatg gaatgaaaac tttcagaaaa 1200gtgaaagatt ccagctctga
aaaaaagaga gaaagatcaa agagacagtt taaaaatagt 1260tcagatgtcg
atattgggga aaagattgaa aacaggacag aaagatctga tgtcctggat
1320ggcaaaaggg gtgcagaaga tcccggtttt attttcaata atgaacagct
ggctcagatg 1380aatgaacagc tggctcaggt gaatgaacta aagaaaatga
cccttcaaac tggctttgaa 1440caaggtgaca gagaaaatgt actgtgtaat
aaaaaggaga aaagaataac aaatgagcaa 1500gaggaaacat actctttatc
ccaaagttca ggtaaatttc accaggagag taaatttgat 1560aagggtcaga
attccctaac ttgtaataaa agtaaagctt ctagacagac atttgtgatt
1620cacaaattag aaaaagataa cttactccca aaccaaaagg ataaagtaac
catttatgaa 1680aacctagacg tcacaaatga atttcacaca gccaatcttt
ccaccaaaga taatggaaat 1740ttatgtgatt atgggaccca caatatattg
gatttgaaaa agtatgtcac tgatattcaa 1800ccctcagagc aaaatgaatc
aaacattaat aagcttagaa agaaagtaaa ccggaagaca 1860gaaataattt
ctggaatgaa ccacatgtat gaagataatg ataaagatgt ggtgcatggc
1920ctaaaaaaag gtaatttttt tttcaaaacc caagaggata aagaacctat
ctctgaaaac 1980atagaagttt ccaaagagct tcaaatccca gctctttcta
ctagagataa tgaaaatcaa 2040tgtgactata ggacccagaa tgtgttgggt
ttgcaaaagc agatcaccaa tatgtacccc 2100gttcagcaaa atgaatcaaa
agttaataag aagcttaggc agaaagtaaa tcggaagaca 2160gaaataattt
ctgaagtgaa tcatttagat aatgacaaaa gtatagaata cacagttaaa
2220agtcactcac tctttttaac gcaaaaagat aaggaaataa tccccggaaa
cctagaagac 2280ccaagtgagt ttgaaacacc tgctctttct accaaagata
gtggaaacct gtatgattct 2340gagattcaaa atgttttggg ggtgaaacat
ggccatgata tgcaacctgc ttgtcaaaat 2400gattcaaaaa taggtaagaa
gcctagacta aatgtatgtc aaaagtcaga aataattcct 2460gaaaccaacc
aaatatatga gaatgataac aaaggtgtac atgacctaga aaaagataac
2520ttcttctctc taaccccaaa ggataaagaa acaatttctg aaaatctaca
agtcacaaat 2580gaatttcaaa cagttgatct tctcatcaaa gataatggaa
atttatgtga ttatgacacc 2640cagaatatat tggagttgaa aaagtatgtt
actgatagga aatctgctga gcaaaatgaa 2700tcaaaaataa ataagctcag
gaataaagtg aattggaaga cagaaataat ttctgaaatg 2760aaccagatat
atgaggataa tgataaagat gcacatgtcc aagaaagcta tacaaaagat
2820cttgatttta aagtaaataa atctaaacaa aaacttgaat gccaagacat
tatcaataaa 2880cactatatgg aagtcaacag taatgaaaag gaaagttgtg
atcaaatttt agattcctac 2940aaagtagtta aaaaacgtaa gaaagaatca
tcatgcaagg caaagaacat tttgacaaaa 3000gctaagaaca aacttgcttc
acagttaaca gaatcttcac agacatctat ctccttagaa 3060tctgatttaa
aacatattac tagtgaagca gattctgatc caggaaaccc agttgaacta
3120tgtaagactc agaagcaaag cactaccact ttgaataaaa aagatctccc
ttttgtggaa 3180gaaataaaag aaggagagtg tcaggttaaa aaggtaaata
aaatgacatc taagtcaaag 3240aaaaggaaga cctccataga tccttctcca
gagagccatg aagtaatgga aagaatactt 3300gacagcgttc agggaaagtc
tactgtatct gaacaagctg ataaggaaaa caatttggag 3360aatgagaaaa
tggtcaaaaa taagccagac ttttacacaa aggcatttag atctttgtct
3420gagatacatt cacctaacat acaagattct tcctttgaca gtgttcgtga
aggtttagta 3480cctttgagcg tttcttctgg taaaaatgtg ataataaaag
aaaattttgc cttggagtgc 3540tccccagcct ttcaagtaag tgatgatgag
catgagaaga tgaacaagat gaaatttaaa 3600gtcaaccgga gaacccaaaa
atcaggaata ggtgatagac cattacagga cttgtcaaat 3660accagttttg
tttcaaataa cactgctgaa tctgaaaata agtcagaaga tctatcttca
3720gaacggacaa gcagaagaag aaggtgtact cctttctatt ttaaagagcc
aagcctcaga 3780gacaagatga gaagatga 3798201265PRTHomo sapiens 20Met
Glu Cys Pro Val Met Glu Thr Gly Ser Leu Phe Thr Ser Gly Ile1 5 10
15Lys Arg His Leu Lys Asp Lys Arg Ile Ser Lys Thr Thr Lys Leu Asn
20 25 30Val Ser Leu Ala Ser Lys Ile Lys Thr Lys Ile Leu Asn Asn Ser
Ser 35 40 45Ile Phe Lys Ile Ser Leu Lys His Asn Asn Arg Ala Leu Ala
Gln Ala 50 55 60Leu Ser Arg Glu Lys Glu Asn Ser Arg Arg Ile Thr Thr
Glu Lys Met65 70 75 80Leu Leu Gln Lys Glu Val Glu Lys Leu Asn Phe
Glu Asn Thr Phe Leu 85 90 95Arg Leu Lys Leu Asn Asn Leu Asn Lys Lys
Leu Ile Asp Ile Glu Ala 100 105 110Leu Met Asn Asn Asn Leu Ile Thr
Ala Ile Glu Met Ser Ser Leu Ser 115 120 125Glu Phe His Gln Ser Ser
Phe Leu Leu Ser Ala Ser Lys Lys Lys Arg 130 135 140Ile Ser Lys Gln
Cys Lys Leu Met Arg Leu Pro Phe Ala Arg Val Pro145 150 155 160Leu
Thr Ser Asn Asp Asp Glu Asp Glu Asp Lys Glu Lys Met Gln Cys 165 170
175Asp Asn Asn Ile Lys Ser Lys Thr Leu Pro Asp Ile Pro Ser Ser Gly
180 185 190Arg Thr Thr Gln Pro Leu Ser Thr Gln Asp Asn Ser Gly Val
Leu Phe 195 200 205Leu Lys Glu Asn Asn Gln His Val Tyr Gly Leu Asp
Asp Ser Glu His 210 215 220Ile Ser Ser Ile Val Asp Val Pro Pro Arg
Glu Ser His Ser His Ser225 230 235 240Asp Gln Ser Ser Lys Thr Ser
Leu Met Ser Glu Met Arg Asn Ala Gln 245 250 255Ser Ile Gly Arg Arg
Trp Glu Lys Pro Ser Pro Ser Asn Val Thr Glu 260 265 270Arg Lys Lys
Arg Gly Ser Ser Trp Glu Ser Asn Asn Leu Ser Ala Asp 275 280 285Thr
Pro Cys Ala Thr Val Leu Asp Lys Gln His Ile Ser Ser Pro Glu 290 295
300Leu Asn Cys Asn Asn Glu Ile Asn Gly His Thr Asn Glu Thr Asn
Thr305 310 315 320Glu Met Gln Arg Asn Lys Gln Asp Leu Pro Gly Leu
Ser Ser Glu Ser 325 330 335Ala Arg Glu Pro Asn Ala Glu Cys Met Asn
Gln Ile Glu Asp Asn Asp 340 345 350Asp Phe Gln Leu Gln Lys Thr Val
Tyr Asp Ala Asp Met Asp Leu Thr 355 360 365Ala Ser Glu Val Ser Lys
Ile Val Thr Val Ser Thr Gly Ile Lys Lys 370 375 380Lys Ser Asn Lys
Lys Thr Asn Glu His Gly Met Lys Thr Phe Arg Lys385 390 395 400Val
Lys Asp Ser Ser Ser Glu Lys Lys Arg Glu Arg Ser Lys Arg Gln 405 410
415Phe Lys Asn Ser Ser Asp Val Asp Ile Gly Glu Lys Ile Glu Asn Arg
420 425 430Thr Glu Arg Ser Asp Val Leu Asp Gly Lys Arg Gly Ala Glu
Asp Pro 435 440 445Gly Leu Phe Phe Asn Asn Glu Gln Leu Ala Gln Met
Asn Glu Gln Leu 450 455 460Ala Gln Val Asn Glu Leu Lys Lys Met Thr
Leu Gln Thr Gly Phe Glu465 470 475 480Gln Gly Asp Arg Glu Asn Val
Leu Cys Asn Lys Lys Glu Lys Arg Val 485 490 495Thr Asn Glu Gln Glu
Glu Thr Tyr Ser Leu Ser Gln Ser Ser Gly Lys 500 505 510Phe His Gln
Glu Ser Lys Phe Asp Lys Gly Gln Asn Ser Leu Thr Cys 515 520 525Asn
Lys Ser Lys Ala Ser Arg Gln Thr Phe Val Ile His Lys Leu Glu 530 535
540Lys Asp Asn Leu Leu Pro Asn Gln Lys Asp Lys Val Thr Ile Tyr
Glu545 550 555 560Asn Leu Asp Val Thr Asn Glu Phe His Thr Ala Asn
Leu Ser Thr Lys 565 570 575Asp Asn Gly Asn Leu Cys Asp Tyr Gly Thr
His Asn Ile Leu Asp Leu 580 585 590Lys Lys Tyr Val Thr Asp Ile Gln
Pro Ser Glu Gln Asn Glu Ser Asn 595 600 605Ile Asn Lys Leu Arg Lys
Lys Val Asn Arg Lys Thr Glu Ile Ile Ser 610 615 620Gly Met Asn His
Met Tyr Glu Asp Asn Asp Lys Asp Val Val His Gly625 630 635 640Leu
Lys Lys Gly Asn Phe Phe Phe Lys Thr Gln Glu Asp Lys Glu Pro 645 650
655Ile Ser Glu Ser Ile Glu Val Ser Lys Glu Leu Gln Ile Pro Ala Leu
660 665 670Ser Thr Arg Asp Asn Glu Asn Gln Cys Asp Tyr Arg Thr Gln
Asn Val 675 680 685Leu Gly Leu Gln Lys Gln Ile Thr Asn Met Tyr Pro
Val Gln Gln Asn 690 695 700Glu Ser Lys Val Asn Lys Lys Leu Arg Gln
Lys Val Asn Arg Lys Thr705 710 715 720Glu Ile Ile Ser Glu Val Asn
His Leu Asp Asn Asp Lys Ser Ile Glu 725 730 735Tyr Thr Val Lys Ser
His Ser Leu Phe Leu Thr Gln Lys Asp Lys Glu 740 745 750Ile Ile Pro
Gly Asn Leu Glu Asp Pro Ser Glu Phe Glu Thr Pro Ala 755 760 765Leu
Ser Thr Lys Asp Ser Gly Asn Leu Tyr Asp Ser Glu Ile Gln Asn 770 775
780Val Leu Gly Val Lys His Gly His Asp Met Gln Pro Ala Cys Gln
Asn785 790 795 800Asp Ser Lys Ile Gly Lys Lys Pro Arg Leu Asn Val
Cys Gln Lys Ser 805 810 815Glu Ile Ile Pro Glu Thr Asn Gln Ile Tyr
Glu Asn Asp Asn Lys Gly 820 825 830Val His Asp Leu Glu Lys Asp Asn
Phe Phe Ser Leu Thr Pro Lys Asp 835 840 845Lys Glu Thr Ile Ser Glu
Asn Leu Gln Val Thr Asn Glu Phe Gln Thr 850 855 860Val Asp Leu Leu
Ile Lys Asp Asn Gly Asn Leu Cys Asp Tyr Asp Thr865 870 875 880Gln
Asn Ile Leu Glu Leu Lys Lys Tyr Val Thr Asp Arg Lys Ser Ala 885
890 895Glu Gln Asn Glu Ser Lys Ile Asn Lys Leu Arg Asn Lys Val Asn
Trp 900 905 910Lys Thr Glu Ile Ile Ser Glu Met Asn Gln Ile Tyr Glu
Asp Asn Asp 915 920 925Lys Asp Ala His Val Gln Glu Ser Tyr Thr Lys
Asp Leu Asp Phe Lys 930 935 940Val Asn Lys Ser Lys Gln Lys Leu Glu
Cys Gln Asp Ile Ile Asn Lys945 950 955 960His Tyr Met Glu Val Asn
Ser Asn Glu Lys Glu Ser Cys Asp Gln Ile 965 970 975Leu Asp Ser Tyr
Lys Val Val Lys Lys Arg Lys Lys Glu Ser Ser Cys 980 985 990Lys Ala
Lys Asn Ile Leu Thr Lys Ala Lys Asn Lys Leu Ala Ser Gln 995 1000
1005Leu Thr Glu Ser Ser Gln Thr Ser Ile Ser Leu Glu Ser Asp Leu
1010 1015 1020Lys His Ile Thr Ser Glu Ala Asp Ser Asp Pro Gly Asn
Pro Val 1025 1030 1035Glu Leu Cys Lys Thr Gln Lys Gln Ser Thr Thr
Thr Leu Asn Lys 1040 1045 1050Lys Asp Leu Pro Phe Val Glu Glu Ile
Lys Glu Gly Glu Cys Gln 1055 1060 1065Val Lys Lys Val Asn Lys Met
Thr Ser Lys Ser Lys Lys Arg Lys 1070 1075 1080Thr Ser Ile Asp Pro
Ser Pro Glu Ser His Glu Val Met Glu Arg 1085 1090 1095Ile Leu Asp
Ser Val Gln Gly Lys Ser Thr Val Ser Glu Gln Ala 1100 1105 1110Asp
Lys Glu Asn Asn Leu Glu Asn Glu Lys Met Val Lys Asn Lys 1115 1120
1125Pro Asp Phe Tyr Thr Lys Ala Phe Arg Ser Leu Ser Glu Ile His
1130 1135 1140Ser Pro Asn Ile Gln Asp Ser Ser Phe Asp Ser Val Arg
Glu Gly 1145 1150 1155Leu Val Pro Leu Ser Val Ser Ser Gly Lys Asn
Val Ile Ile Lys 1160 1165 1170Glu Asn Phe Ala Leu Glu Cys Ser Pro
Ala Phe Gln Val Ser Asp 1175 1180 1185Asp Glu His Glu Lys Met Asn
Lys Met Lys Phe Lys Val Asn Arg 1190 1195 1200Arg Thr Gln Lys Ser
Gly Ile Gly Asp Arg Pro Leu Gln Asp Leu 1205 1210 1215Ser Asn Thr
Ser Phe Val Ser Asn Asn Thr Ala Glu Ser Glu Asn 1220 1225 1230Lys
Ser Glu Asp Leu Ser Ser Glu Arg Thr Ser Arg Arg Arg Arg 1235 1240
1245Cys Thr Pro Phe Tyr Phe Lys Glu Pro Ser Leu Arg Asp Lys Met
1250 1255 1260Arg Arg 12652145PRTyeast 21Met Glu Ser Leu Lys Lys
Lys Phe Leu Lys Gln Asn Arg Glu Ile Ile1 5 10 15Lys Ile Asn Thr Gln
Leu Ser Ile Lys Ile Arg Glu Ser Glu Asn Glu 20 25 30Ile Gln Asp Leu
Ile Gln Glu Asn Phe Thr Leu Lys Ser 35 40 452245PRTyeast 22Val Glu
Asp Leu Lys Lys Lys Gln Ile Arg Gln Tyr Lys Glu Ile Ile1 5 10 15Arg
Ile Ser Lys Ala Gln Ser Ile Arg Ile Lys Glu Leu Gln Leu Glu 20 25
30Asn Glu Arg Leu Leu Ser Glu Asn Ile Asp Leu Arg Thr 35 40
452345PRTyeast 23Val Glu Asn Ile Arg Gln Ser Tyr Ser Arg Gln Asn
Ser Leu Leu Ala1 5 10 15Lys Asp Asn Ser Ile Leu Lys Ile Lys Val Asn
Ser Leu Glu Lys Lys 20 25 30Ile Ser Gln Leu Val Gln Glu Asn Val Thr
Leu Arg Ser 35 40 452445PRTNeurospora crassa 24Leu Glu Leu Leu Arg
Arg Lys Phe Leu Arg Gln Asn Arg Asp Ile Ala1 5 10 15Arg Val Asn Ser
Thr Gln Ser Leu Arg Ile Arg Gly Leu Glu Asn Glu 20 25 30Cys Ala Arg
Leu Leu Ser Glu Asn Leu Glu Leu Arg Gly 35 40
452545PRTDactylicapnos macrocapnos 25Gly Ser Lys Val Glu Gln Gln
Tyr Lys Leu Leu Asn Ala Glu Leu Met1 5 10 15Asp Gln Val Gln Lys Gln
Arg Leu Glu Ile Gly Glu Tyr Arg Lys Arg 20 25 30Val Ile Ser Leu Glu
Arg Glu Ile Met Asp Ile Arg Glu 35 40 452627PRTyeast 26Gly Arg Glu
Lys Leu Arg Arg Ser Val Lys Val Ile Asn Tyr Ala Ile1 5 10 15Pro Ser
Leu Arg Thr Lys Leu Arg Arg Asp Phe 20 252727PRTyeast 27Pro Asp Gly
Arg Ser Arg Arg Glu Arg Lys Lys Val Asn Tyr Ala Leu1 5 10 15Pro Gly
Leu Arg Thr Lys Leu Arg Arg Asn Phe 20 252828PRTyeast 28Ser Phe Thr
Arg Thr Arg Arg Thr Arg Gly Lys Ala Val Asp Tyr Thr1 5 10 15Leu Pro
Ser Leu Arg Ala Lys Met Arg Arg Pro Ser 20 252928PRTNeurospora
crassa 29Glu Thr Ser Arg Pro Ser Arg Arg Ala Arg Ala Ala Ile Ser
Tyr Thr1 5 10 15Glu Pro Asn Leu Arg Asp Lys Met Arg Arg Pro Thr 20
253027PRTDactylicapnos macrocapnos 30Asn Ser Ala Arg Pro Ser Arg
Ser Cys Arg Pro Thr Ser Leu Val Glu1 5 10 15Pro Ser Leu Lys Asn Lys
Leu Arg Asn Gly Ser 20 253128PRTCaenorhabditis elegans 31Thr Val
Arg Arg Gln Arg Ser Ala Lys Met Asn Ile Lys Ser Leu Lys1 5 10 15Glu
Pro Ser Gly Lys Asp Lys Leu Arg Arg Pro Gly 20 253229PRTArabidopsis
thaliana 32Thr Val Gly Arg Pro Ser Arg Gln Ala Ala Glu Lys Ile Lys
Ser Tyr1 5 10 15Lys Glu Pro Ser Leu Lys Glu Lys Met Arg Gly Gly Phe
20 253329PRTArabidopsis thaliana 33Ser Val Gly Arg Pro Ser Arg His
Ala Ala Glu Lys Val Gln Ser Tyr1 5 10 15Arg Glu Val Ser Leu Arg Val
Lys Met Arg Arg Lys Cys 20 253428PRTmouse 34Ala Val Ala Leu Thr Lys
Arg Arg Cys Ser Thr Ile Lys Ser Tyr Lys1 5 10 15Glu Pro Thr Leu Ala
Ser Lys Leu Arg Arg Gly Asp 20 253525PRTmouse 35His Pro Met Arg Arg
Lys Arg Gln Cys Val Pro Leu Asn Leu Thr Glu1 5 10 15Pro Ser Leu Arg
Ser Lys Met Arg Arg 20 253628PRTHomo sapiens 36Ala Val Ala Leu Pro
Lys Arg Arg Cys Thr Ala Ser Val Asn Tyr Lys1 5 10 15Glu Pro Thr Leu
Ala Ser Lys Leu Arg Arg Gly Asp 20 253726PRTHomo sapiens 37Ser Glu
Arg Thr Ser Arg Arg Arg Arg Cys Thr Pro Phe Tyr Phe Lys1 5 10 15Glu
Pro Ser Leu Arg Asp Lys Met Arg Arg 20 253821DNAArtificial
Sequence?TriplEx 38ctcgggaagc gcgccattgt g 213922DNAHomo sapiens
39cctggctgaa tcagctttgg tg 224023DNAArtificialhSgo1 40aagucuacug
auaaugucuu att 234123DNAArtificial SequencehSgo2 41aagcacuacc
acuuugaaua att 234221DNAArtificial SequencehSgo1 42gugagccucu
gugaaucaat t 21 4321DNAArtificial SequencehSgo2 43gcucucauga
acaauaacut t 21 4421DNAArtificial SequencesiRNA,Target1
44gagugaucac gauuucuaat t 21 4521DNAArtificial
SequencesiRNA,Target2 45aacgggcauu ugaauaugaa a 21
* * * * *